Podcasts about BID

Retirement planning is becoming more complex as careers grow less linear, lifespans extend, and financial decisions start earlier in life. From early-career savers to small business owners and those approaching retirement, people are asking how to build financial security while staying flexible in an unpredictable world.In this Ask Me Anything episode of The Bid, host Oscar Pulido is joined by Jaime Magyera, Head of BlackRock's U.S. Wealth Advisory and Retirement Businesses, to answer listener-submitted questions on retirement realities. Jaime shares perspectives drawn from her work with individual savers, financial advisors, and small business owners across the country.The conversation reframes retirement as the freedom to choose what comes next, rather than a fixed end point. Jaime discusses the importance of starting early, maintaining discipline through market cycles, and building plans that can adapt as careers, families, and goals evolve. The episode also explores the role of professional advice, the challenges facing non-traditional career paths, and why preparation — not prediction — is central to long-term financial resilience.Key insights include:• Why retirement is best viewed as a transition, not a destination• How starting early and staying invested can shape long-term outcomes• Why flexible planning matters for non-linear careers and families• What advisors should consider when working with small business owners• How professional advice differs from social and digital guidance• Why preparedness and emergency savings support financial resilienceKey moments in this episode:00:00 Introduction to The Bid00:50 Meet Jamie Magyera: Insights on Retirement Planning01:48 Transitioning into Retirement: Key Considerations04:05 Financial Planning for Younger Generations06:41 Non-Traditional Retirement Timelines09:56 Advisors and Small Business Owners: Planning for the Future12:45 How To Build Long-Term Client Relationships15:33 The Value of Professional Financial Advice17:28 Conclusion and Key Takeaways18:16 Closing Remarks and Up Nextretirement planning, financial security, wealth planning, capital markets, long-term investing,Sources: BlackRock's Read On Retirement Survey, September 2025This content is for informational purposes only and is not an offer or a solicitation. Reliance upon information in this material is at the sole discretion of the listener. Reference to any company or investment strategy mentioned is for illustrative purposes only and not investment advice. In the UK and non-European Economic Area countries, this is authorized and regulated by the Financial Conduct Authority. In the European Economic Area, this is authorized and regulated by the Netherlands Authority for the Financial Markets. For full disclosures, visit blackrock.com/corporate/compliance/bid-disclosures.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Kiera is joined by the tooth-healer himself, Jason Dent! Jason has an extensive background in pharmacy, and shares with Kiera where his pharmaceutical experience has bled over into dentistry. This includes the difference between anti-quag and anti-platelet and which medications are probably safe, what to do to shorten the drag time in the pharmacy, how to write prescriptions most efficiently, and more. Episode resources: Subscribe to The Dental A-Team podcast Schedule a Practice Assessment Leave us a review Transcript: The Dental A Team (00:00) Hello, Dental A Team listeners. This is Kiera and today is a really awesome and unique day. It is, think the second time I've had somebody in the podcast studio with me live for a podcast and it's the one and only Jason Dent. Jason, how are you? I'm doing well. Good morning. Thanks for having me. It is crazy. I I watch Instagram real like this all the time where people are like in the podcast and they're hanging out on two chairs and couches and now look at us. We're doing it. Cheers. Cheers.   That was a mic cheer for those of you who are only listening, but yeah, Jace, how does this feel to be on the podcast? It's weird. Like I was not nervous at all talking about it. I got really nervous as soon as you hit play. So if I stumble over my words, please forgive me ahead of time. Well, Jason, I appreciate you being on the podcast because marketing had asked me to do a topic about teledentistry and I was like, oh shoot, that's like not my forte at all. so   You and I were actually chatting in the hot tub. call it Think Tank session and you and I, we have a lot of good ideas that come from that Think Tank. A lot of business. no phones. That's why. We do leave our phones out. But I was talking to Jason and this is actually a podcast we had talked about quite a while ago. Jason has a lot of information on pharmacy. And if you don't know, Jason isn't really, we were going through all of it last night. It's kind of a mock in the tub. And I think it's going to be great because I feel like this is an area, I'm working at Midwestern and   knowing about how dentists, pharmacology was surely not your favorite one. Jason actually helps a lot of dentists with their clearances. And so we were talking about it and I like it will just be a really awesome podcast for you guys to brush up on pharmacology, different things from a pharmacist's side. So Jason, welcome. Thank you. Yeah, no, we were talking about it and here's like, what should I talk about on the podcast next? I have all these different topics and she's like, what do you know? And the only real interaction I have with dentists is doing clearances for procedures. We get them all the time, which makes sense.   Lots of people are on blood thinner, I've always told Kiera, like, hey, I could talk about that. Like, that's kind of a passion of mine. I'm not a dentist. Or my name is Jason Dent. So in Hebrew, Jason means tooth. No, no, no, sorry. Nerves are getting to me. Jason means healer and Dent means tooth. So my name means tooth healer. So, here's a little set. Hold on, on, hold Can we just talk about? I brought that up before you could talk about it more. So.   My name means tooth healer but I did not become a dentist. I know you wanted me to become a dentist. did. I don't know why. I enjoy medicine. I know what you're going to get to already. The things you're going to ask me. There's been years of this. But nevertheless, that's my name. We'll get that out of the way. But you did give me a great last name. So I mean, it's OK. You're All is fair and love here. SEO's up for that. But yeah, Jason, I'm going to get you right into the show. And I'm going to be the host. And we're going to welcome to the podcast show. Jace, how are you?   Good, good, good. Good, good, good. So by getting into clearances, right? This is what you're kinda talking about with you know, before we get to clearances, I actually wanted Jason, for the listeners who don't know you, who haven't talked to you, who don't know, let's kinda just give them like, how did you go from, Kiera wanted you to be a dentist, to now Jason, you are on the podcast talking as our expert on pharmacy. fantastic. I've always really loved medicine, a ton. As a kid getting headaches and taking Excedrin, like you just feel like a miserable pile of crap.   and then you take two pills and all of a sudden you feel better. Like that's amazing, like how does that happen? Also getting ear aches as a kid, just being in so much pain and then taking some medicine and you start feeling a lot better. I always had a lot of appreciation for that. I've always been mechanically inclined. I went to, started doing my undergrad and took biology and learned about ATP synthase, which is a spinning enzyme that's inside the mitochondria, like a turbine engine. I used to work on small engines on my dirt bike and thought that is so cool. So I really got wrapped up into chemistry.   All the mechanics of chemistry really pulled me in. I'm not getting goosebumps. checking. I usually get goosebumps when I think about chemistry. But it's so cool. You think an engine's awesome, like pistons and camshafts and pressures, the cell is the same thing. It's not as loud, so it's not as cool. But it's fascinating. that's why we're like. ⁓   chemistry and really got into coagulation. So I did my residency after pharmacy school. we went to Arizona for three years. ⁓ You did and your main focus, you were never wanting to be the guy behind the counter. No, I haven't done that. Yeah. No, I love them though. I've always really want to go clinical. ⁓ But I love my retail ⁓ pharmacists. They're amazing resources. And ⁓ I use the retail pharmacist every day still to this day, but I went more the clinical route, really love the chemistry aspect of it.   did my doctorate degree and then I did my residency in Reno. Reno's kind That's how we got here everybody. Welcome to Reno. Strategically placed because I was really interested in critical medicine and where we're located we cover a huge area. So we pull in to almost clear, we go clear to Utah, clear to California, all of Northern Nevada. We get cases from all over. So we actually are kind like the first hub of care for lot of areas. So we really get an eclectic mixture of patients that come in that need-   all kinds of different cases that are coming to them. So it's what I really wanted. So I did my residency in critical care there. And then for the next 10 years, I worked in vascular medicine with my final five years being the supervisor of the clinic. Ran all the ins and outs of that. So my providers, two doctors were on our view. So when we talk about dentistry, talk about production, those kinds of things, totally get it. My doctors were the exact same way, my vascular providers. ⁓   There's some pains there, right? You wanna be seeing patients as much as possible, being able to help as many people, keeping the billing up. And had other nurse practitioners, four practitioners, a fleet of MAs, eight pharmacists. We also had that one location we had, going off the top of my head, I think we had eight locations running as well. And we took care of all the different kinds of vascular cases that came to us. Most common was blood clots, ⁓ which is just a...   which is an easier way of saying VTE. There's so many different ways to say a blood clot. Like you might hear patients say, I've had a PE or a DVT or a venous thromboembolism or a clot in my leg, right? They're all clots, but in different locations. Same with an MI, and MI can be a clot as well. ⁓ there's a lot of, everybody's kind of saying the same thing, but sometimes the nomenclature can make it sound hard, but it really is actually pretty simple.   No. And Jason, I love that you went through, you've been in like, and even in your, ⁓ when you were getting your doctorate, you were in the ER. You also worked in retail pharmacy. remember you having a little sticker on your hand. And retail pharmacy, I have a lot of respect for those guys. They have a lot of pressure on them. and then you also, ⁓ what was that test that you had to take that? I don't know. You were like studying forever for it. ⁓ board certification for, ⁓ NABP. Yeah. So I did that board certification as well.   And now you've moved out of the hospital side onto another section in your career. Now in the insurance, right? So it's really, really interesting. So now I'm on the other side reading notes and evaluating clinical appropriateness and trying to help patients with getting coverage and making those kinds of determinations. So yeah, I've really jumped all over. Really love my clinical days. I know. don't I don't I do miss them. But yeah, kind of had a good exposure to a lot of.   pharmacy a lot a lot of dentists actually with all the places that come through which Jason I really appreciate that and honestly I know you are my spouse and so it's fun to have you on but when I go into conversations like this I don't know any of this information and so finding experts and Jason I think here's me talk more about dentistry and my business than I do hear about him on pharmacy so as we were chatting about this I really realized you are a wealth of knowledge because you've been on the clinical side so you've done a lot of patient care and you've seen how   medications interact and I know you've had a few scares in your career and ⁓ you've known some physicians that have had a few scares and ⁓ you've seen plenty of patients pass away working in the ER and gosh in Arizona drownings were such a big deal. I remember when you were in the ER on your rotations I'd be like who died today? Like tell me the stories and you've really seen and now going on to the insurance side I felt like you could just be such a good wealth of knowledge because I know dentists are sometimes so   I would say like maybe just a little more anxious when it comes to medications. I know that dental students from Midwestern were like here was like four months and we had to like pass it, learn it. And Jason, you've done four years plus clinical residency, plus you've been in it. And something I really love about Nevada Medicine is they've been so collaborative with you.   like your heart, your cardiologist, they diagnose and then they send to you to treat with medicine and... Yeah, I've been really lucky being here in Reno too. The cardiology team has been amazing to work with. We started a CHF program, sorry, congestive heart failure program for patients. So we would collaborate with cardiologists. They'd see the cardiologists and then they send them to the pharmacist to really manage all the medications. So there's pillars of therapy ⁓ called guideline directed medical therapy and the pharmacist would take care of all that. So that's gonna be your...   your beta blockers, your ACEs, your ARBs, your Entresto, which would be a little bit better, spironolactone. So just making sure that all these things are dosed appropriately, really monitoring the heart, and make sure that patients are getting better. we've had real positive outcomes when the, sorry, this is totally off topic. do, talk about that study. When we looked at when patients were coming to see our pharmacists in our clinic that we started up, the patients were half as likely to be readmitted. And this was in 2018, and our pharmacists,   We're thinking about all the medications. We're usually adjusting diabetes medications too at the same time. Just kind of naturally just taking care of all the medications because we kind of got a go ahead from the providers, a collaborative practice agreement that we could make adjustments to certain medications within certain parameters. So we weren't going rogue or maverick, but we were definitely trying to optimize our medications as much as possible. And then years later, some studies came out with, I'm sure you've seen Jardins and Farseegh. not trying to, I'm not.   I don't get any kickback from them. I have no conflicts to share. But because our pharmacists were really optimizing that medication, those medications were later shown to reduce hospitalizations and heart failure, even though they're diabetes medications. Fascinating. So it wasn't really the pharmacists. It was just the pharmacists doing as much as they can with all the tools that were in front of them. And then we found out that the patients were going back to the hospital.   half as much as regular patients. So, yeah, being here, it's been so amazing to work with providers here. the providers here want help, want to help patients, don't have an ego. I mean, I just, it's awesome. I love it. I do love how much I think Jason sees me geek out about dentistry and I watching Jay's geek about his pharmacy and how much he loves helping patients. And ⁓ really that was the whole idea of, all right.   Dentistry has pharmacy as a part of it. And I know a lot of dentists are sending in clearances and I know working in a chair side, it would be like, oh no, if they're on warfarin or on their own blood clot, you guys, honestly don't even know half of what I'm talking about because this is not my jam, which is why Jason's here. But I do know that there was always like, well, we got to talk with their provider. And so having Jason come in and just kind of explain being the pharmacist that is approving or denying or saying yes or no to take them off the blood thinners in different parts, because you have seen several dental   I don't know what they're called. What is it? Clarence's? that what comes to you? don't even know. All day my mind, it's like, here is the piece of paper that gets mailed to you to the pharmacist and then you mail it back. So whatever that is. But Chase, let's talk about it because I think you can give the dentist a lot of confidence coming from a pharmacist. What you guys see on that side. When do you actually need to approve or disapprove? Let's kind of dig into that. Yeah. Well, first of all, I think I'm not a replacement for any kind of clinical judgment whatsoever. Every patient's different. But the American Diabetes Association, you   I work with diabetes a lot. American Dental Association has some really great guidelines on blood thinners and I would always reference them. I actually looked at their website today. Make sure I'm up to speed before I get back on this again. They have resources all around making decisions for blood thinners. And I think the one real important thing in putting myself in the shoes of a dentist or any kind of staff that's around a patient that's in a chair, if they say I'm on a blood thinner, right, a flag goes up. At least in my mind, that's what goes up.   Like, okay, how do we get across this bridge? And I think the important thing to really distinct right then when they say they're on a blood thinner is that is kind of a slang word for a lot of different medications, right? Like it's the overarching word that everybody pulls up saying, I'm on a blood thinner. It's like, okay, but I don't know what say. It's like, I have a car. You're like, okay, do you have a Mazda? Do you have?   Toyota, Honda, what do you have? or even worse it'd be like saying I have a vehicle, right? So when somebody says they're on a blood thinner, it opens up a whole box of possibilities of what they're Blood thinners are also, doesn't, when they're taking these types of medications that are quote unquote a blood thinner, it doesn't actually thin the blood, like adding water to the blood, if that makes sense, or like thinning paint, or like thinning out a gravy, right? It doesn't do the same thing. Blood thinners, really what they're doing is they're working on the blood, which.   which is really cool, try not to tangent on that. ⁓ When they're working on the blood, it's not thinning it per se, but it's making it so that the proteins or platelets that are in it can't stick together and make a cloth quite as easy. So whenever somebody's on a blood thinner, I usually ask, what's the name of the blood thinner that you're on? It's not bad that they use that slang, that's okay, on the same page, but it's really broken into two different classes. There's anticoagulant and antiplatelet.   And a way to kind of remember which is which, when residents would come through our clinics, the way that I teach them is a clot is like a brick wall. You know, it's not always a brick wall. Usually the blood is a liquid going through. But once they receive some kind of chemical message, it starts making a brick wall with the mortar, which is the concrete between the and the bricks, the two parts. When it's an anti-quagent, it's working on that mortar part. When it's an anti-platelet, it's working on the bricks part, right? You need both to make a strong clot or strong brick wall.   But if you can make one of them not work, obviously like if your mortar is just water, it's not working, right? You're not gonna make a strong brick wall. So that's kind of the two deviants right there. So that's what I do in my mind real quickly to find out because antiplatelets are usually, so that's gonna be like your Plavix, Ticagrelor, Brilinta. And hold on, antiplatelets are bricks? Good job, bricks. They're the bricks. And so the reason I was thinking you could remember this because I'm, antiplatelets, it's a plate and a plate is more like a brick.   And anti coagulant, I don't know why quag feels like mortar to me, like quag, like, know, it's like slushy in the blood, like it's coagulating. It's a little bit of that, like, honestly, I'm just thinking like coagulated blood is a little bit more mortar-ish. And so platelet is your plate, like a brick, and anti-quag is like.   the gilly between the bricks. Okay, okay, I got it. Yeah, so there's an exception to every rule, but when they're on that Don't worry, this is Kiera, just like very basic. You guys are way smarter listening to this, and that's why Jason's here. No, no, you helped me pass pharmacy school. When we were doing all the top 200, you helped me memorize all know what flexorill is, all right? That's a muscle relaxant. Cyclo? I don't know that part. It's a cyclo, because you guys are cycling and flexing. I don't actually know. just know it's a muscle relaxant, so that's about as far as I got. When we're looking at antitick platelets, so that's the brick part, so that's going to be your, you know,   Hecagrelor, Breitlingta, Clopidogrel is the most common one. It's the cheapest one, so probably see that one the most. Those, I mean, there's an exception to every rule, but that's generally being used after like a stent's placed in the heart. It can be used for VTE, there's some out there, but that's pretty rare. But also for some valves that are placed in the hearts, it can be used for that as well. So antiplatelet, really thinking more like a cardiac event, right? Like I said, there's always an exception to every rule, but that's kind of where my mind goes real quickly, because we're gathering information from the patient.   They're on anticoagulant. Those are like going to be the new ones that you see commercials for all the time. So Xeralto, Alequis, those are the two big ones right now. They're replacing the older one. And also we were supposed to do a disclaimer of this is current as of today because the ADA guidelines do change. this will be current as of today. And Jason, as a pharmacist, is always looking up on that. I had no clue that you are that up to speed on dental knowledge. so just throwing it out there that if you happen to catch his podcast,   a few years back that obviously check those guidelines for sure. But the new ones are the Xarelto and Eloquist. They're replacing the older ones of warfarin. Warfarin's been around for a really long time. We've seen that one. Those are anti-coagulants. So when you're looking, when a patient says that, generally they're on that medication because they've possibly had a clot in the past or they have a heart condition called atrial fibrillation. Those are kind of the two big ones. Like I said, there's always caveats to it, but that's kind of where my mind goes real quickly. And then,   as far as getting patients cleared, the American Dental Association has really good resources on their website. You can look at those and they're always refreshing that up. They even say in their own words that there's limited data around studying patients in the dental chair and with anticoagulants or anti-platelets. It's pretty limited. There's a few studies, some from 2015, some from 2018. There's one as recent as 2021, which is nice. But really, all of those studies come together and it's really more of an expert consensus.   And with that expert consensus, they have kind of simplified things for dentistry, which is really nice. ⁓ comparing that to, we have more data for like total hip replacement, total knee replacement. We have a lot of data and we know really what we should be doing around then. But going back to dentistry, we don't have as much information, so they always say use clinical judgment, but they do give some really great expert guidance on that. So if a patient's on an anticoagulant, ⁓   they generally recommend that it doesn't need to be stopped unless there's a high bleeding risk for a patient. as a provider or as a clinician in the practice, you can be looking at high bleeding risk. Some things that make an oral procedure a little bit lower risk is one, it's in the compressible site, right? Like we can actually put pressure on that site. That's the number one way to stop bleeding is adding pressure. It's not like it's in the abdominal cavity where we can't get in and can't apply pressure. So number one, that kind of reduces the bleeding risk.   is number one. Two, we can add topical hemostatic agents. Dentists would know that better than me. There's a lot of topical ways to do that. So not only pressure, but there's those things as well. And also, but there are some procedures that are a little bit more likely to bleed. And that's where you and dentists would come in hand in What's the word in APO? Oh, the APOectomy. I got it right. Good job. like, didn't you tell me last night that the ADA guideline was like what?   three or four or more teeth? great question. So you can extract one to three teeth is what their expert consensus One to three teeth without. Without really managing or stopping anticoagulation or doing anything like that. I think that's some good guidance from them. I'm gonna add a Jasonism on that though. So with warfarin, I do see why dentists would be a little bit more conservative or worried about stopping the warfarin because warfarin isn't as stable as these newer agents. Warfarin, the levels.   quote unquote levels can go really high, they can go really low. And if the warfarin levels are high, they're more likely to bleed. So I do think it makes sense to have a really recent INR. That's how we measure what the warfarin's doing. I think that makes a lot of sense, but the ADA guidelines really go into the simplification version of all these blood thinners. Generally, it's recommended to not stop them because the risk of stopping them outweighs the benefit of stopping them in almost every case. Almost every case.   ⁓ So when you're with that patient, right, they say I'm on a blood thinner, finding out which kind of blood thinner that they're on, you find out that they're on Xeralto, right? How long have you been on Xeralto for? I've been on it for years. You don't know exactly why, but if they haven't had any recent bleeding, you're only gonna remove one tooth. ⁓ You can do what's called a HasBlood score. That kind of looks at the bleeding risk that they'd have. That'd be kind of going a notch above, but in my mind, removing one tooth isn't a real serious bleeding risk. I'd love to hear from my dentist friends if they...   disagree, right, but ADA says one to three tooth removals, extractions, that's the fancy word. Extractions, yeah, for extracting teeth out. Is not really that invasive. Sure. It's not that high risk, so it's usually perfectly fine. So if a patient was on Xarelto, ⁓ no other, this is in a vacuum, right? I'm not looking at any other factors, which you should be looking at other factors. I would be perfectly fine to just remove one to two.   And when those clearances come in, because dentists do send them, talk about what happens. You guys were working in the hospital and you guys would get these clearances all the time. do. We get them so often. I mean, we get like four or five a day. We'd love to give it to our students, student pharmacists, and ask them what to do. And they would usually look up the American Dental Association guidelines and come up with something. We're like, yep, that's what we say too. In fact, we say it so many times a day that we have a smart phrase.   which just blows in the information real quickly and faxes it right back to the So it's like a copy paste real quick. So what I wanted to point out when Jason told me this is dentists like hearing this and learning this, this can actually save you guys a ton of time to be able to be more confident, to not need to send those clearances on. And we were actually talking last night about how I think this might be a CYA for dentists. like, as we were talking, I think Jason, you seeing so many other aspects of medicine, like you've literally seen patients die, you've seen other areas.   And so coming from that clinical vantage point, we were realizing that dentists, we are so blessed to live in an injury. I enjoy dentistry because possibly there's someone dying, not super high, luckily in dentistry. The only time that I have actually had a doctor have a patient pass away, and it was only when they were completely sedated and doing ⁓ some other things, but that was under the care of an anesthesiologist. And so that's really our high, high risk. And so hearing this, Jason,   That was one of the reasons I wanted him to come on is to give you doctors more confidence of do we have to always send to a pharmacist? I mean, hearing that on the pharmacy side, they're just sending these back and not to say to not see why a to not cover this because you might be questioning like, well, do I really need to? But you also were talking about some other ways of so number one, you guys are just going to copy back the 88 guidelines. So so 88 guidelines. Yeah. And I think that that gives a lot of confidence to a provider or a dentist is that you can go to the 88 guidelines and read them, right? Like you're listening to some   nasally monotone pharmacist on a podcast. Rumor has it, people love him at the hospital. were like, you're the voice, he's been told he has a good radio So for the clinic, I was the voice. Like, yeah, you've reached the vascular clinic, right? And they're like, oh my gosh, you're the voice. But sorry, you me distracted. That'll be your next career, Jace. You're going to be a radio host. OK. I would love that. I love music. But you're hearing from a nasally guy, but you can actually read the ADA guidelines. You just go right to the ADA, click on Resources, and under Resources, it has the   around anticoagulants, I think that's the best way to get a lot of confidence about it because they have dentists who are the experts making calls on these. I'm just reiterating what they say, but I think it makes a lot of sense to help providers. And the reason why my heart goes out to you as well is having the providers that used to work underneath me, they're always looking for our views, which is a fancy way of making sure that they're drilling and filling. Can I say that? Yeah, can say drilling and filling. They're being productive, right? They're being productive, right?   They're always looking to make sure if a patient's canceling, like get somebody in here. Like I need to be helping people all day long. That's how I, we keep the lights on. That's how I help as many people. And so if you have a patient coming in the chair and it has an issue, they say I'm on Xeralto. Well, you can ask real quickly, why are you on Xeralto? I had a clot 10 years ago. my gosh. Well, yeah, we're pretty good to go. Then I'm not worried. We're only removing one tooth or we're just doing a cavity or a cleaning. Something like that. Shouldn't be an issue whatsoever because there's experts in the dental. ⁓   in the dental society, the ADA guidelines that recommend three teeth or less, minimally invasive. They really recommend if it's gonna be really high bleeding risk. And clinically, that's where you would come in, ⁓ or yourself. know, apioectomy is one that's like on the fence line. I don't know where implants set. though, and like we were talking, implants aren't usually like a date of procedure. Most people aren't popping in, having tooth pain, and we're like, let's do an implant. Now sometimes that can be the case, but typically that one's gonna have   a few other pieces involved. And so that is where you can get a clearance if you want to. ⁓ But we were really looking at this of like so many dentists that I know that you've seen will just send in these clearances because they are. And I think maybe a way to help dentists have more confidence is because you know, I love routines. I love to not have to remember things. So why don't we throw it in, have the team member set it up where every quarter we just double check the ADA guidelines. Are there any updates? Are there any other things that we need to do on that? That way you can just see like   getting into the language of this, of what do I need to do? Because honestly, you guys, know pharmacy was not a big portion for it, so, recommending different parts, but I think this is such a space where you can have confidence, and there's a few other things I wanna get to, and I you- I some pearls too. Okay, go. I'm so when she get me into talking about drugs, I'm not gonna stop. So, some other things around that too is these newer blood thinners like Xarelto Eloquist, they now have reversal agents, so a lot of providers in the past were really worried about bleeding because we can't turn it off. We can turn those off. Warfarin has reversal as well, right?   So I'm looking at these patients. It's really low risk. It's in the mouth, generally speaking. Very rarely are they a high bleeding risk. Now if you're doing maxillofacial surgery, this does not apply, right? This does not apply whatsoever. you're like general dentist, you're pediatric dentist. Yeah, yeah, and it's kind of on the fly. So just trying to really help you to be able to take care of those patients on the moment, have that confidence, look at the ADA guidelines, have that in front of you. I don't think it's a bad thing to ever...   check with their provider if you need to. If you're thinking, I feel like I should just check with the provider, I would never take that away from you. But I just want to kind of steer towards those guidelines that I have to help. But what did you want to share? No, yeah, I love that. And I think there were just a few other nuggets that we were chatting about last night that can help dentists just kind of get things passed a little bit easier. So you were mentioning that if they were named to their cardiologist, what was it? was like, who is the last? Great question. Yeah, when a patient's on a blood thinner,   It could be prescribed by the cardiologist. It could be prescribed by the family provider or could have been punted to like a vascular clinic like where I was working. It can go to any of those. And when you send that fax, right, if it goes to the cardiologist and it's supposed to go to the family care provider, like it just kind of goes, goes nowhere, right, from there. So I think it's a really good idea to find out who prescribed it last. If the patient doesn't know who prescribed their blood thinner last, you can call their pharmacy. I call pharmacies all day long.   I have noticed in the last year, they are way easier to get a hold of, which has made my job a lot easier, working on the insurance portion. So reaching out to the pharmacy, finding out who that provider is and sending it to them, because they should be able to help with that. I thought that was a good shift in verbiage that you had of asking instead of like the cardiologist, because that's who you would assume was the one. But you said like so many times you guys would take care of them, and then they go back to family practitioner, and you guys would get the clearances, but you couldn't clear because you weren't overseeing. So just asking the patient.   who prescribed their medication for them last time. That way you can send the clearance to the correct provider. then- And they might not know. You know patients, right? They're like, I don't know, my mom's or else, I don't know who gave it to me. Somebody told me I need to be on this. But at least that could be another quick thing. And then also we were talking last night about-   ⁓ What are some other things that dentists can do when like writing scripts to help them get what I think like overarching theme of everything we discussed is one how to help dentists have less I think drag through pharmacy. ⁓ Because pharmacy can take a little while and so perfect we now know the difference between anti-quag and anti-platelet. We know which medications are probably safe. We know we can check the ADA guidelines so that we were not having to do as many clearances. We also know if they're on a medication to find out and we do need a clearance.   who we can go to for the fastest, easiest result. And now, in talking about prescriptions, you had some really interesting tips that you could share with them. Yeah, so with writing prescriptions, right, pharmacies are pharmacies. So I'm not gonna say good thing or bad thing. There are challenges working with pharmacies. I'm not gonna play that down at all. ⁓ If you're writing prescriptions and having issues and kickbacks from pharmacies, there's some interesting laws around ⁓ writing prescriptions. Say that you're trying to ⁓ prescribe   augmentin, you know, 875 BID, and you tell the patient, hey, I want you to take this twice a day for seven days, and then you put quantity of seven, because you're moving fast, right? You want it for seven days, quantity of seven. Quantity would actually be 14, right? It's not that big of a deal. Anybody with common sense would say if you're taking a pill for twice a day for seven days, you need 14 tablets. But LAHA doesn't allow pharmacists to make that kind of a change, unfortunately. They have to follow what you're saying there. So you're going to get a...   An annoying callback that says, you wrote for seven tablets. I know you need 14. Is that OK? Just delays things, right? So ⁓ I really like the two letters QS. That's Q isn't queen. S isn't Sam. Yeah. It stands for quantity sufficient. So you don't have to calculate the amount of any medication that you're doing. So for me, as a pharmacist, when I was taking care of patients, I hated calculating the amount of insulin they would need for an entire month. So I would say.   Mrs. Jones needs 15, I'd say 15 units ⁓ QD daily. ⁓ And then I say QS, quantity sufficient, ⁓ 90 day supply through refills. So the pharmacy can then go calculate how much insulin that they need. I don't have to even do that. So anytime you're prescribing anything, I like that QS personally. So that lets the pharmacy use ⁓ common sense, as I like to call it, instead of giving you a call. I think that's super helpful. I also thought of one thing too.   going back to blood thinners is when it's kind of like a real quick, like they're not gonna have you stop the blood thinner at all. like you're seeing if you can stop the blood thinner for a patient, there's some instances it's just not gonna happen. And that's whenever they've been, they've had a clot or a stroke or a heart attack within the last three months. Three months. Yeah, that's kind of like the.   Because so many people are like, they had a heart thing like six years ago. And so I think a lot of my dentists that I worked with were like, we got to stop the blood thinners. But it sounds like it's within three months. Yeah, well, I'm just the time. Like this is general broad strokes. What I'm just trying to say is when you want to expect a no real quick. Got it. Right. So because benefits of stopping a blood thinner within those first three months of an event is very, very risky versus the, you know, the benefit of reducing a little bit of blood coming out of the mouth. Right. Like that's not that bad.   when somebody's had a stroke or a heart attack or pulmonary embolism, a clot in the lung, like we can't replace the lung, heart or brain very easily. We can replace blood a lot better. We've got buckets of it at most hospitals have buckets of it, right? So I'm always kind of leaning towards I'd rather replace blood than tissue at all times. So that's kind of a quick no. If they've had one those events in the last three months, we are really, really gonna watch their brain instead of getting.   root canal, right? Like really worried about them. So you'll just say no. And they could the dentist still proceed with the procedure or would you recommend like a three month wait? Or is it provider specific way the pros and cons because sometimes you need to get that tooth out. Great question. think then it's going to come into clinical. That's that's when you send in the clearance, right? Like, and it's great to reach out to the provider who's managing it for you. But I think it's kind of good to know exactly when you get a quick no quick no is going to be less than three months.   ⁓ Or when it's going to be like a kind of a typical, yeah, no problem. If it's been no greater than six months, they're on the typical anticoagulants or alto eloquence. Nothing crazy is going on for them. You're only removing two teeth. This is very, very low risk. But again, I'd urge everybody to read the ADA guidelines. That way you feel more comfortable with it. I'm not as eloquent as they do. They do a real good job. So I don't want to take any of their credit. I think they do a real good job of simplifying that and making you feel confident with providing.   more timely care for patients. Which is amazing. And Jayce, one last thing. I don't remember what it was. You were talking about the DEA and like six month rule. yeah. Let's just quickly talk about that and then we'll wrap this because this is such a fascinating thing for me last night. Yeah. So when comes to prescribing controlled substances, most providers have to have a DEA license. OK. First of all, though, what's your take on dentist prescribing controlled substances? ⁓ I don't think, you know, I worked on the insurance side of things. Right. And I look at the requirements for the   as the authorizations, what a patient, the criteria a patient needs to hit in order to qualify for certain medications. A lot of times for those controlled substances, they have pretty significant issues going on, like fibromyalgia or cancer-related pain or end-of-life care versus we don't, in all my scanning thread, I don't have a ⁓ perfect picture memory. Sure. But I don't usually see oral.   pain in there. There is some post-operative pain that can be covered for those kind of medications but I really recommend to keep those lower and in fact in a lot of our criteria it recommends you know have they tried Tylenol first, they tried, have they filled NSAIDs or are they contraindicated with the patient. So really they should be last line for patients in my two cents but there's always going to be a caveat to the rule right? Of course. comes through that has oral cancer and you're taking   like that would make sense to me. Got it, so then back to the DEA. Yeah, okay. Okay, ready. So as a provider, you should be checking the, if you're doing controlled substances, you should be checking the prescription drug monitoring program, or sometimes called the PDMP, looking to see if patients are getting ⁓ controlled substances from another provider. So it's really just a check and balance to make sure that they're not going from provider to provider to getting too many narcotics and causing self harm or harm to others.   And so with checking that PDMP before prescribing, I think a lot of providers do that. A lot of softwares that I'm aware of, EMRs, electronic medical records, sometimes have links so that you can do that more quickly. However, I don't think it's as intuitive that they need to be checking that every six months in some states. And like here in Nevada, you're supposed to be checking it every six months, not for a patient, but for your actual DEA registration to see if anybody else is prescribing underneath you. Because if you don't check that every six months, you could get in some serious trouble with...   not only DEA, but even more the Board of Pharmacy and your state. Now, I don't know all 50 states, so I check with your state to see if you need to be checking that every six months, but set an alarm just to check that real quickly, keep your nose clean. ⁓ I've had providers, I've had to remind to do that. And if somebody was using your account, prescribing narcotics, you'd never know unless you went and checked that PDMP.   Yeah, I remember last night you were like, and if that was you, I would not want to be you. The Board of Pharmacy is going to be real excited to find you. So that was something where I was like, got it. So, and we all know I'm big on let's make it easy. And Jason, I love that you love this so much and you just brought so much value today. And like also for me, it's just fun to podcast. fun. Yeah. But I got a nerd out on my world a little bit. Bring it into yours. I work with dentists or at least you know, when I was working in Vascular Clinic all day long. Great questions that would come through. Yeah.   So I think for all of us, as a recap on this is number one, I think setting yourself ⁓ some cadences. So maybe every quarter we check our ADA guidelines and we check our, what is it, PDMP. PDMP. so each state, so they call it Prescription Drug Monitoring Program. We need that. Yeah, but there are different acronyms in different states, though. That's just what it's called in Nevada. I forget what it is in California, but you can check your state's prescription monitoring program, make sure that opioids aren't being prescribed under your name. Got it. So we just set that as a cadence.   We know one to three teeth most likely if they're on a blood thinner is According to the 88 as of today is good to go You know things that are going to get a quick know are going to be within the last three months of the stroke the heart attack or the Clot I'm thinking like the pulmonary embolus. Yeah, that's what we're trying to prevent   Those are gonna be quick knows and then if we're prescribing, let's do QS. We've got quantity is sufficient so that we're not getting phone calls back on those medications that we are. And then on narcotics, just being a bit more cautious. Of course, this is provider specific and in no way, or form did Jason come on here to tell you you are the clinical expert.   Jason's the clinical expert on medications. And if you guys ever have questions, I know Jason, you geek out and you want to talk to people so that anyone wants to chat shop. Be sure to reach out and we'll be able to connect you in. we've even talked about possibly, so let me know listeners. You can email in Hello@TheDentalATeam.com of ask a pharmacist anything. I talked to Jason. I was like,   We'll just have them like send in questions and maybe get you back on the podcast or we do a webinar. But any last thoughts, Jace, you've got of pharmacy and dentistry as we as we wrap up today? No, I think that's pretty much it. So check the ADA guidelines. I think it's really good to have cross communication between professions. Right. If you're working with the pharmacy, CVS, Walgreens or something like that or Walmart, I know that it can be challenging. Right. They're under different pressures. You're under different pressure. So I think ⁓ just coming in with an understanding, not being angry at each other.   you know what mean, is super beneficial and working together. When it comes to it, every dentist that I've talked to is actually worried about their patient. Every pharmacist that I've worked with is really worried about the patient as well. So we're trying to accomplish the same thing, but we have different rules and our hands are bound in different ways that annoy each other, right? Like I know Dr. Jones, want 14 tablets, but you said seven. And I know Common Sense says I should give them 14, but I've got to make that change.   knowing that their hands are tied by the law. They can't use as much common sense, which is aggravating. I mean, that's why I love what I gotta do here. I gotta just kind of help a lot more and use common sense and improve patient care. But those kinds of things I think are really beneficial as you work together and then not being so afraid of blood thinners, right? So I think those guidelines do a great job of giving you confidence and not worrying about the side effects. And there's a lot of things that you can do locally for bleeding.   You have a lot of control over that. I think that's pretty cool, the tools they have. Yeah. And at the end of the day, yes, you are the clinician. You are the one who is responsible for this. so obviously, chat, but I think collaborating, talking to other pharmacists, talking to them in your state, finding out what are the state laws, things like that I think can be really beneficial just to give you peace of mind and confidence. And again, dentistry, are maybe a bit more risk adverse because luckily we don't have patients dying That's great thing. Yeah, that's fantastic. I want my dentists to be risk adverse. I think so too. But Jason, I appreciate you being on the podcast today.   And for all of you listening, ⁓ more confidence, more clarity, more streamline to be able to serve and help our patients better. if we can help you in any way or you've got more questions, reach out Hello@TheDentalATeam.com. And as always, thanks for listening. I'll catch you next time on the Dental A Team podcast.  

Aaron Judge will repeat as the cover athlete on MLB The Show '26. -Why Never Mike Trout? -Free Agents Still Remaining -Top Starting Pitchers In Baseball -Dallas's AEW Twin -Where Does Eugenio Suárez Go? Use promo code “Jared” to get up to $1000 in bonus credits AND a special pick on Underdog! PLAY HERE: https://play.underdogfantasy.com/pc-d2PyPbHAPu Sign up for your one-dollar-per-month trial and start selling today at https://shopify.com/dead Get 20% off your DeleteMe plan when you go to join https://deleteme.com/BID and use promo code BID. 0:00 - Dallas's Twin 6:06 - Merch 13:52 -Free Agents 23:08 -Top Starters 47:11 -Judge Cover 56:23 - Trout No Cover 1:03:30 - Final Thoughts Learn more about your ad choices. Visit megaphone.fm/adchoices

Hedge fund strategies are gaining renewed attention as market volatility rises and traditional stock and bond diversification becomes less reliable. With inflation uncertainty, shifting monetary policy, and growing macro instability, investors are reassessing how different sources of return and risk management show up across capital markets.In this episode of The Bid, host Oscar Pulido speaks with Mike Pyle, Deputy Head of BlackRock's Portfolio Management Group, about how hedge fund strategies work and why they are being re-examined in today's environment. Mike explains what defines hedge fund strategies, how their flexibility seeks to allow managers to express views more precisely, and why they can play different roles within portfolios depending on investor objectives.They explore common misconceptions around hedge fund strategies, including the idea that they are inherently high risk or designed solely to outperform equities. Mike outlines how these strategies span a wide range of risk profiles and can be used for diversification due to their potentially lower correlation to traditional assets. The conversation also examines why macro volatility since 2021 has created a more favorable backdrop for hedge fund strategies, and how their ability to either navigate or reduce macro exposure is shaping investor interest.Key moments in this episode:00:00 Introduction: Navigating Uncertainty in Today's Market03:57 Debunking Myths About Hedge Funds07:36 The Growing Interest in Hedge Funds Strategies12:18 Hedge Funds vs. Other Alternatives16:31 Evolution of the Hedge Fund Industry18:28 Key Takeaways for Investors19:41 Conclusion and Next UpKey insights include:• What hedge fund strategies are and how they differ from traditional investments• Why lower correlation, not market outperformance, is often the core objective• How higher volatility and macro uncertainty are reshaping portfolio construction• How hedge fund strategies compare with other alternatives like private markets and infrastructure• Why scale and multi-strategy platforms are changing the hedge fund landscapehedge fund strategies, capital markets, portfolio diversification, alternatives investing, market volatility, megaforcesThis content is for informational purposes only and is not an offer or a solicitation. Reliance upon information in this material is at the sole discretion of the listener. Reference to any company or investment strategy mentioned is for illustrative purposes only and not investment advice. In the UK and non-European Economic Area countries, this is authorized and regulated by the Financial Conduct Authority. In the European Economic Area, this is authorized and regulated by the Netherlands Authority for the Financial Markets. For full disclosures, visit blackrock.com/corporate/compliance/bid-disclosures.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This week, we discuss Moltbot (née Clawdbot) taking over, Apple's new AirTags, and finding Enterprise AI ROI. Plus, the tragic demise of the TV dinner. Watch the YouTube Live Recording of Episode 557 Runner-up Titles The Podcasters' Choice I was biding my time I just want to sell something I believe in What if you didn't get chard Chard as a Service Let's be cool The Human League Spinning tapes talking to each other Artisanal tape dispensers Buying into the Panopticon Why should only Facebook know where I am? Root access to your life The AirTag Family Circus comic Jar of Airtags Hold my beer open source The Value of AI is intuitively obvious OK, we're done. Talk to you guys next week. Rundown Clawdbot Rebrands to Moltbot After Trademark Request From Anthropic - Laravel News Clawdbot users are snapping up the Mac Mini — and it's under $500 at Amazon Enterprise AI ROI is still elusive. What IT can do to fix it. It's not "culture." Apple Silicon machine learning code may become more easily portable to Nvidia hardware Apple introduces new AirTag with expanded range and improved findability MFi Program Cords, Cyborgs & Cold Cases: Grandpa Dancy's Operating System for Life Anthropic launches interactive Claude apps, including Slack and other workplace tools AMD Quietly Funded A Drop-In CUDA Implementation Built On ROCm: It's Now Open-Source Relevant to your Interests On Running a Startup of Claude Code Agents: What You Get For a Billion Tokens a Month Hundreds of Millions of Audio Devices Need a Patch to Prevent Wireless Hacking and Tracking Guiding the future of Chainguard OS: Announcing the FUD Committee Andy Jassy on Healthcare Betting on Prediction Markets Is Their Job. They Make Millions. How Intel Came Crashing Back to Earth After Its Trump Bump Intel Shares Slide as Costs Pile Up in Bid to Meet AI Demand Querying and Ingest issues in EU The A.I. Start-Up Soap Opera Riveting Silicon Valley Listener Feedback Aaron Delp is hiring for a Technical Marketing Engineer in the EU. ,more in Slack Conferences cfgmgmtcamp 2026, February 2nd to 4th, Ghent, BE. Coté speaking, live SDI recording with Andrew Clay Shafer. DevOpsDayLA at SCALE23x, March 6th, Pasadena, CA Use code: DEVOP for 50% off. Devnexus 2026, March 4th to 6th, Atlanta, GA. Use this 30% off discount code from your pals at Tanzu: DN26VMWARE30. I was going to moderate this panel, but now I'm not. Also, this one. They'll be super-cool! KubeCon EU, March 23rd to 26th, 2026 - Coté will be there on a media pass. VMware User Groups (VMUGs): Amsterdam (March 17-19, 2026) - Coté speaking. Minneapolis (April 7-9, 2026) Toronto (May 12-14, 2026) Dallas (June 9-11, 2026) Orlando (October 20-22, 2026) SDT News & Community Join our Slack community Email the show: questions@softwaredefinedtalk.com Free stickers: Email your address to stickers@softwaredefinedtalk.com Follow us on social media: Twitter, Threads, Mastodon, LinkedIn, BlueSky Watch us on: Twitch, YouTube, Instagram, TikTok Book offer: Use code SDT for $20 off "Digital WTF" by Coté Sponsor the show Recommendations Brandon: The Cloudpod Grizzlies Owner Robert Pera Linked to Russia's "Crimes Against Humanity" Matt: Oxide & Friends 2026 Predictions - “Deep Blue” Coté: CNCF Annual Survey for 2025, I finally read it closely-ish.

In this special episode of The Heart of Rural America, host Amanda Radke is joined by her husband, Tyler Radke, for a behind-the-scenes preview of their second annual President's Day Bull Sale at Radke Land & Cattle, located just north of Mitchell, South Dakota.Whether you're a rancher looking to invest in elite Angus and Limousin genetics, a fan of rural entrepreneurship, or just love a great story of resilience and family legacy—this episode delivers.Takeaways:What makes the 2026 bull sale offering truly unique: age-advantage Angus bulls, standout yearlings, and elite donor genetics.Details on exclusive embryo and flush opportunities from premier donor cows like Hart Whitney and GMC Isabel.The exciting live Bid on Beef auction, selling premium Angus beef direct to consumers nationwide.A special guest appearance by NFL legend Don Beebe, who will deliver a message of perseverance before the beef auction.Why this event is more than a cattle sale—it's a celebration of rural America, community, and legacy ranching.Featured Genetic Offerings:Pineview Red States x Hart Whitney 25282 progenyMason Landmark, SS Identified, and Blue Duck siresLimousin options from camouflage and Federal Reserve linesEmbryos and flushes from top females including Baldridge Isabel and Linz Lady 3125Exclusive Bid on Beef lots – Prime, dry-aged All-American Angus beef delivered to your doorFollow Amanda Radke on social media and subscribe to The Heart of Rural America for more episodes featuring the voices shaping agriculture, rural values, and constitutional freedoms.Presented by Bid on Beef | CK6 Consulting | CK6 Source | Real Tuff Livestock Equipment | Redmond RealSalt | Dirt Road Radio | All American Angus Beef | Radke Land & CattleUse code RADKE for $10 off your next All American Angus Beef order at www.BidOnBeef.comSave on Redmond Real Salt with code RADKE at https://shop.redmondagriculture.com/Check out Amanda's agricultural children's books here: https://amandaradke.com/collections/amandas-booksLearn more about Bulletproofing Your Direct-To-Consumer Beef Enterprise: https://amandaradke.com/products/bulletproof-your-beef-business

Bid on Sonny signed shirts here: https://mws.com/event/30-01-2026-son-heungmin-limited-edition-frame-auction-special-6 We're buzzing after a proper away performance in Frankfurt, even with half the squad missing and lads playing out of position. We get into the back three, why it finally felt calm, and why Paulinha and Spence basically shut down a whole side of the pitch. Then it's January, injuries are months not days, so do we sign bodies or hold our nerve and avoid buying rubbish for the sake of it? Plus, Xavi Simons, Premier League football stinks, and yes, we absolutely talk City and the pure entertainment of Arsenal fans panicking. Learn more about your ad choices. Visit podcastchoices.com/adchoices

ALSO: ...New IMPD Chief Makes History.. Indiana's Bid to Lure Away Chicago Bears Gains SteamSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Brand new Miami Marlins player Pete Fairbanks joins BID! -Choosing The Marlins -Experience In Free Agency -Short-Term Contracts Trend -Bullpen Roles -Lockout Concern -Pitching Philosophy -Marlins Young Talent Use promo code “Jared” to get up to $1000 in bonus credits AND a special pick on Underdog! PLAY HERE: https://play.underdogfantasy.com/pc-d2PyPbHAPu 0:00 - Pete Fairbanks joins BID! 4:00 - Choosing Marlins / Free Agency 9:10 - Kyle Tucker's Short-Term, High AAV Contract 12:15 - Offseason Adjustments 17:45 - Benefits Of Miami 19:40 - Lockout Concern 21:45 - Bullpen Roles 26:30 - Dodgers Free Agency 30:26 - Hot Tub Time Machine 36:00 - Clubhouse Vibes Learn more about your ad choices. Visit megaphone.fm/adchoices

In this powerful solo episode of The Heart of Rural America, host Amanda Radke shares 12 actionable strategies designed to help small business owners, rural entrepreneurs, and family farmers succeed in 2026. From understanding your business financials to building a brand rooted in authenticity and faith, Amanda lays out a roadmap for sustainable, values-based growth.If you're ready to scale your business, streamline your systems, and lead with clarity and purpose this year, don't miss this value-packed episode—complete with a free downloadable PDF checklist to help you take immediate action.What You'll Learn in This Episode:How to know and use your business financials to make smarter decisionsThe importance of delegation and building a strong, aligned teamSimple systems that save time and increase productivityHow to define and market your rural business authenticallyEmail list strategies and pricing tips for small business ownersSuccession planning and legacy building for family farmsThe role of self-care and faith in business leadershipAmanda's upcoming bull and female sale event announcementHow to download the free 12-Step Business ChecklistFollow Amanda Radke on social media and subscribe to The Heart of Rural America for more episodes featuring the voices shaping agriculture, rural values, and constitutional freedoms.Presented by Bid on Beef | CK6 Consulting | CK6 Source | Real Tuff Livestock Equipment | Redmond RealSalt | Dirt Road Radio | All American Angus Beef | Radke Land & CattleUse code RADKE for $10 off your next All American Angus Beef order at www.BidOnBeef.comSave on Redmond Real Salt with code RADKE at https://shop.redmondagriculture.com/Check out Amanda's agricultural children's books here: https://amandaradke.com/collections/amandas-booksLearn more about Bulletproofing Your Direct-To-Consumer Beef Enterprise: https://amandaradke.com/products/bulletproof-your-beef-business

The European Union has officially and metaphorically switched on the IRIS2 secure satellite communications network, the homegrown 10.6 billion Euro European alternative to Starlink. ESA and EUMETSAT have finalized their agreement on the EPS-Sterna constellation. Planet Labs has signed a new agreement with the Surveying and Mapping Authority of Slovenia, and more. Remember to leave us a 5-star rating and review in your favorite podcast app. Be sure to follow T-Minus on LinkedIn and Instagram. T-Minus Guest Our guest today is  Les Lake,  Vice President of Business Development at All Points Logistics.  You can connect with Les on LinkedIn, and learn more about All Points Logistics on their website. Selected Reading EU Deploys First Satellite Service in Bid to Limit US Dependence (Bloomberg) EU space agency signs contract to launch Galileo satellites with Ariane 6  (Reuters) EUMETSAT and ESA set to start the implementation of EPS-Sterna (EUMETSAT) Planet Signs Enterprise Agreement with Slovenian Government to Support Agriculture, Urban Planning and Disaster Management (Business Wire) NASA lines up WDR for SLS ahead of Artemis II (NSF)  NASA Launches Its Most Powerful, Efficient Supercomputer (NASA) ESA's Biomass goes live with data now open to all (ESA)  Share your feedback. What do you think about T-Minus Space Daily? Please take a few minutes to share your thoughts with us by completing our brief listener survey. Thank you for helping us continue to improve our show.  Want to hear your company in the show? You too can reach the most influential leaders and operators in the industry. Here's our media kit. Contact us at space@n2k.com to request more info. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this week's episode of the Coin Stories News Block powered exclusively by Ledn, we cover these major headlines related to Bitcoin, macroeconomics, and global finance: Shutdown fears are back -- Bitcoin & stocks are feeling the pressure Gold and silver just hit fresh all-time highs as Davos screamed "uncertainty" Ray Dalio's warning goes mainstream: print money or face a debt crisis Japan's bond stress could spill into U.S. Treasuries and push global rates higher Who's likely to be next Fed Chair? We explain. Bitcoin reenters the spotlight, plus rapid-fire: UBS crypto, debanking lawsuit drama, and BitGo's IPO moment --- The News Block is powered exclusively by Ledn – the global leader in Bitcoin-backed loans, issuing over $9 billion in loans since 2018, and they were the first to offer proof of reserves. With Ledn, you get custody loans, no credit checks, no monthly payments, and more. My followers get .25% off their first loan. Learn more at www.ledn.io/natalie  ---- Order my new intro to Bitcoin book "Bitcoin is For Everyone": https://amzn.to/3WzFzfU  ---- Read every story in the News Block with visuals and charts! Join our mailing list and subscribe to our free Bitcoin newsletter: https://thenewsblock.substack.com  —- References mentioned in the episode: Treasury Rate Check Boosts Yen, Weakens Dollar Speculation Mounts: Japan to Buy Yen with U.S. Help? Ray Dalio Warns of Breakdown in the Monetary Order Dollars' Shrinking Role in Global FX Reserves Institutions are Reducing Dollar FX Exposure Ken Griffin: Japan Bond Market is "Explicit Warning" French Central Bank Governor Dismisses Bitcoin  Coinbase CEO Spars With Central Bank Governor BlackRock CIO's Fed Chair Nomination Odds Skyrocket  BlackRock CIO's Bid for Fed Chair Gaining Traction Rick Rieder's Comments on Bitcoin Allocation U.S. Market Structure Bill Faces Weeks of Delay BitGo IPO's on the New York Stock Exchange UBS Plans to Offer Crypto Trading to Clients PwC Survey on Bitcoin's Institutional Adoption Trump Sues JPMorgan Chase for Debanking ---- Upcoming Events: Strategy World 2026 in Las Vegas on February 23-26th - Use code HODL for discounted tickets: https://www.strategysoftware.com/world26  Bitcoin 2026 will be here before you know it. Get 10% off Early Bird passes using the code HODL: https://tickets.b.tc/event/bitcoin-2026?promoCodeTask=apply&promoCodeInput=  ---- This podcast is for educational purposes and should not be construed as official investment advice. ---- VALUE FOR VALUE — SUPPORT NATALIE'S SHOWS Strike ID https://strike.me/coinstoriesnat/ Cash App $CoinStories #money #Bitcoin #investing

In this episode of the Federal Help Center Podcast, Ryan Atencio breaks down a bid-list and search strategy that helps specialty contractors stop missing opportunities—and start getting inbound requests from prime contractors. You'll learn why relying on narrow NAICS searches limits growth, how using multiple PSC codes (including general construction) opens the door to subcontracting work, and how specialty trades like HVAC, roofing, electrical, and facilities maintenance can position themselves as the go-to local expert on military bases and federal installations. The episode also explains how responding consistently—even when declining—keeps you top-of-mind with primes, why submitting proposals fast matters more than perfection, and how AI enables teams to compete on shorter timelines without burning out. Key Takeaways Search broader than your specialty. Specialty contractors should track construction PSC codes to find subcontracting paths and prime partners. Bid lists beat daily searches. The goal is getting primes to send you opportunities—so one estimate can support multiple bids. You can't win if you don't submit. Fast, repeatable proposals create momentum—and follow-up requests often signal a win. If you want to learn more about the community and to join the webinars go to: https://federalhelpcenter.com/  Website: https://govcongiants.org/  Connect with Encore Funding: http://govcongiants.org/funding Join 2026 Surge Bootcamp Starting January 31: https://govcongiants.org/surge 

Fantasy and Crime on a Monday First,  a look at this day in History.Then, Lights Out originally broadcast January 26, 1938, 88 years ago, Oxychloride X.   A young crackpot college student invents the universal solvent, with of course nothing to keep in it. Followed by Dragnet starring Jack Webb, originally broadcast January 26, 1954, 72 years ago.  The Big Bid.  A clothing store has been burglarized...the ex-convict assistant manager is suspected. Then, Nick Carter Master Detective starring Lon Clark, originally broadcast January 26, 1947, 79 years ago,  The Case of the Persistent Beggars.  The panhandlers of the city are unionized...and controlled by crooks! Followed by The Shadow starring William Johnstone, originally broadcast January 26, 1941, 85 years ago,  The Ghost of Caleb Mackenzie.   All the family has gathered to celebrate with Uncle Caleb.Finally,  Claudia originally broadcast January 26, 1948, 78 years ago, Discussing the Bid.   The Chinese and the New Englanders. Kathryn Bard and Paul Crabtree star.Thanks to Richard G for supporting our podcast by using the Buy Me a Coffee function at http://classicradio.streamCheck out Professor Bees Digestive Aid at profbees.com and use my promo code WYATT to save 10% when you order! Find the Family Fallout Shelter Booklet Here: https://www.survivorlibrary.com/library/the_family_fallout_shelter_1959.pdfhttps://wardomatic.blogspot.com/2006/11/fallout-shelter-handbook-1962.html

MRKT Matrix - Friday, January 23rd Nasdaq rises, S&P 500 and Dow struggle as Street wraps up wild week (CNBC) S&P 500 Earnings Season Update (FactSet) A Stock Slump Could Slam the Economy (WSJ) Silver Tops $100 as Global Turmoil Fuels Run for Safe Havens (Bloomberg) Five Reasons Gold Is Surging Toward $5,000 an Ounce (WSJ) Rieder's Market Support, Fed Plans Seen as Boon for Chair Job (Bloomberg) Intel Shares Slide as Costs Pile Up in Bid to Meet AI Demand (WSJ) Databricks obtains $1.8 billion in additional debt ahead of IPO (CNBC) Natural gas prices soar more than 60% as winter storm approaches (NBC News) --- Subscribe to our newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://riskreversalmedia.beehiiv.com/subscribe⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ MRKT Matrix by RiskReversal Media is a daily AI powered podcast bringing you the top stories moving financial markets Story curation by RiskReversal, scripts by Perplexity Pro, voice by ElevenLabs

In this episode of the Bioactive Podcast, Dr. Hemant Bid joins Dr. Riley Kirk discussing the often-overlooked world of acidic cannabinoids aka Raw or Unactivated cannabinoids, such as CBGA, THCA, and CBDA. He shares his extensive background in cannabis research and education, emphasizing the therapeutic potential of these compounds, which are non-psychoactive and interact with various non-cannabinoid targets in the body. The conversation also delves into extraction techniques for preserving these cannabinoids, their role in plant defense, and the future of research in this area. Dr. Bid highlights the importance of personalized medicine and the need for more education and understanding in the field of medical cannabis. Join the Bioactive Patreon community for as little as $1/month to ask guests your burning questions, access exclusive content, and connect with Dr. Kirk one-on-one.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ www.Patreon.com/Cannabichem⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Global markets are entering 2026 amid heightened geopolitical uncertainty, structural shifts in the global order, and rapid technological change. Recorded live from the World Economic Forum in Davos, this episode of The Bid examines the macroeconomic and geopolitical forces shaping the year ahead.Host Oscar Pulido is joined by Philipp Hildebrand, Vice Chairman of BlackRock, and Tom Donilon, Vice Chairman of BlackRock and Chairman of the BlackRock Investment Institute. Drawing on conversations with political leaders, policymakers, and business executives in Davos, they reflect on an evolving geopolitical landscape and its implications for markets, governments, and global cooperation.The discussion explores how shifts in U.S. policy are reshaping alliances — particularly between the United States and Europe — and why this period may mark a broader transition away from the post–World War II global framework. Philipp outlines the pressures facing Europe, while Tom examines how national security considerations are increasingly shaping economic policy, trade, and global investment flows.Artificial intelligence emerges as a central theme, viewed both as an economic driver and a geopolitical force. The episode considers AI's role in national security competition, the growing importance of data centers and energy infrastructure, and how concerns around sovereignty, critical minerals, and societal impact are elevating AI from a technological issue to a political one.Key insights· How current geopolitical developments are reshaping the global outlook entering 2026· Why Davos remains a key forum for understanding policy and market sentiment· Where Europe's macroeconomic challenges and opportunities are most pronounced· How AI is increasingly intersecting with geopolitics and national security· What recent U.S.–Europe tensions reveal about future global cooperation· How investors and policymakers are interpreting uncertainty in today's environmentGeopolitics, global macro outlook, Europe economy, World Economic Forum Davos, AI and geopolitics, global markets, policy uncertaintyThis content is for informational purposes only and is not an offer or a solicitation. Reliance upon information in this material is at the sole discretion of the listener. Reference to any company or investment strategy mentioned is for illustrative purposes only and not investment advice. In the UK and non-European Economic Area countries, this is authorized and regulated by the Financial Conduct Authority. In the European Economic Area, this is authorized and regulated by the Netherlands Authority for the Financial Markets. For full disclosures, visit blackrock.com/corporate/compliance/bid-disclosures.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Amanda Radke hosts a property rights rally at the Capitol Rotunda, South Dakota, highlighting the importance of property ownership and the ongoing fight to protect landowners from eminent domain for private gain. The event features speeches from several key figures, including Senator Mykala Voita, Attorney General Marty Jackley, and Senator Mark Lapka who announce a new constitutional amendment to prohibit eminent domain for private gain. The rally celebrates past victories while rallying support for continued efforts to safeguard property rights, emphasizing the unity and determination of South Dakota farmers and ranchers in defending their land and freedoms.Chapters: 00:00 Introduction and Rally Kickoff01:21 Opening Prayer and Pledge02:46 Attorney General Marty Jackley's Speech08:28 Representative Liz May's Statement15:20 Charles and Heather Maude's Story21:27 Senator Lauren Nelson's Address26:45 Speaker Pro Temp Carla Lems's Remarks29:53 Rallying for Victory: The Power of Unity30:19 Key Figures and Their Contributions31:24 The Fight for Property Rights32:39 The AI Bill of Rights34:30 Personal Stories of Struggle and Triumph40:49 The Legislative Battle47:27 A Call to Action: Protecting Our Future54:10 The Power of the People: Achievements and Future GoalsFollow Amanda Radke on social media and subscribe to The Heart of Rural America for more episodes featuring the voices shaping agriculture, rural values, and constitutional freedoms.Presented by Bid on Beef | CK6 Consulting | CK6 Source | Real Tuff Livestock Equipment | Redmond RealSalt | Dirt Road Radio | All American Angus Beef | Radke Land & CattleUse code RADKE for $10 off your next All American Angus Beef order at www.BidOnBeef.comSave on Redmond Real Salt with code RADKE at https://shop.redmondagriculture.com/Check out Amanda's agricultural children's books here: https://amandaradke.com/collections/amandas-booksLearn more about Bulletproofing Your Direct-To-Consumer Beef Enterprise: https://amandaradke.com/products/bulletproof-your-beef-business

Milwaukee Brewer Sal Frelick makes his BID debut! -Playing In Northeast / Boston College -Competitiveness Outweighing Talent -MLB Adjustments / Routine -Relationship With Pat Murphy -Player Role Models, Past & Current -Postseason Experience -NLCS Game 1 Catch / Double Play Use promo code “Jared” to get up to $1000 in bonus credits AND a special pick on Underdog! PLAY HERE: https://play.underdogfantasy.com/pc-d2PyPbHAPu 0:00 - Sal Frelick 3:07 - College Offers, BC Only 4:05 - Playing In New England 10:30 - Competitiveness Breeds Confidence 14:55 - Learning Routine, Making Adjustments 21:15 - Player Profile 22:30 - Role In Lineup 24:05 - Relationship Pat Murphy 26:10 - Role Models In League 29:03 - Pitcher He'd Want To Face 29:54 - Postseason Experiences 31:40 - Insane Catch/Double Play NLCS Game 1 33:15 - How To Get Over The Hump 35:35 - 2025 Roberto Clemente Award Nomination 36:52 - MLB Top 100 List 37:32 - Hot Tub Time Machine Learn more about your ad choices. Visit megaphone.fm/adchoices

In this powerful episode of The Heart of Rural America, host Amanda Radke welcomes back Senator Mark Lapka of South Dakota for a no-holds-barred conversation on property rights, grassroots activism, and groundbreaking legislation that could reshape the future for rural landowners.Fresh off a record-breaking rally at the South Dakota Capitol, Senator Lapka shares exclusive insights on two major legislative efforts:

Don't forget the Square Board on @BettorEdge. Bid on your favorite square, high bid at kickoff gets the square. Rams/Bears board is currently at $47. @BettorEdge Partner Promo Code: PLAYME Signup Link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bettoredge.com/playme⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Peer to peer sports betting with NO JUICE! Click the link for a risk free $20, no deposit required. Join the Free Discord + View Our Podcast Record⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ https://discord.gg/rh2aT8Rg9y YouTube Link:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ https://www.youtube.com/@PlayMeorFadeMePodcast?sub_confirmation=1⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Check out host Bidemi Ologunde's new show: The Work Ethic Podcast, available on Spotify and Apple Podcasts.In this episode, host Bidemi Ologunde traces the blurry line between truth and virality—where influencer "exposés" can ignite celebrity sex scandals, trigger defamation lawsuits, and reward the loudest story rather than the most accurate one. How did scandal become a business model? What happens when deepfakes, rumor accounts, and clout incentives collide with real reputations—and real trauma? And in a surprising twist of the creator economy, how are influencers and OnlyFans creators increasingly positioning themselves as "extraordinary talent" in O-1 visa applications to enter the United States? Along the way, Bid weaves in the non-linear story of a high-end escort whose entry into that world coincided with abuse at home—revealing how private pain can echo through public spectacle. Who gets protected in the attention economy—and who gets used? What does "proof" even mean anymore? And what's the true cost of going viral?Email: bidemiologunde@gmail.comSupport for The Bid Picture Podcast comes from Whole Foods Market. A healthier relationship with tech starts with taking care of the basics—like eating well—so your body and brain aren't running on empty. Whole Foods Market makes it easier to stock your kitchen with ingredients you feel good about, from fresh produce to pantry staples, so you can spend less time scrolling and more time actually living. If you're asked how you heard about Whole Foods Market, please mention The Bid Picture Podcast. Learn more at wholefoodsmarket.com.Support for The Bid Picture Podcast comes from Skylight Calendar—the family-friendly digital calendar that helps everyone stay on the same page. With a quick setup and an easy-to-read display in a shared space, Skylight makes it simple to keep track of school events, practices, appointments, and family plans—so mornings run smoother and everyone knows what's next. Make your home the place where schedules finally make sense. Skylight Calendar—because family life works better when it's shared. If you're asked how you heard about Skylight Calendar, please mention The Bid Picture Podcast. Learn more at myskylight.com.Support the show

AI investment, evolving earnings leadership, and shifting global dynamics are redefining stock market trends as investors enter 2026. Companies are deploying unprecedented capital toward data centers, compute, and productivity-enhancing technologies, while rate cuts and supply-chain realignment reshape the macro backdrop. These forces are changing how fundamentals, valuations, and sector growth patterns show up in equity markets.In this episode of The Bid, host Oscar Pulido speaks with Carrie King, Global CIO of BlackRock's Fundamental Equities group, about the major drivers influencing the 2026 equity outlook. Carrie breaks down why high-level valuations may mask improved corporate quality, how AI-related investment is broadening beyond semiconductors, and why the gap between megacap earnings and the rest of the market may begin to narrow.They also explore how global monetary easing is benefiting emerging markets, why Japan's structural reforms continue to support its equity story, and how diversification is becoming more challenging in a market shaped by a few powerful megaforces. Carrie explains what this means for sector positioning, volatility, and where long-term investors may find underappreciated opportunities.Key moments in this episode:00:00 Introduction: Can Stocks Maintain Momentum in 2026?03:29 AI's Dominance in the Market09:34 Global Investment Trends and Opportunities12:06 Earnings Growth and Sector Performance15:36 Diversification Strategies for Investors17:10 New Year's Resolutions for Investors18:59 Conclusion and Upcoming EpisodesKey insights include:· How AI-driven spending is reshaping earnings patterns and stock market trends· Why equity valuations may be better anchored than headlines suggest· Where the “other 493” may see accelerating earnings growth· How global rate cuts and supply-chain shifts are supporting EM and Japan· Why diversification requires new approaches in a megaforce-driven market· Which sectors—industrials, travel, and healthcare—may offer overlooked potentialstock market trends, AI investing, megaforces, capital markets, equity markets, global investing, sector rotationSources:Written Disclosures In Episode Description:This content is for informational purposes only and is not an offer or a solicitation. Reliance upon information in this material is at the sole discretion of the listener. Reference to any company or investment strategy mentioned is for illustrative purposes only and not investment advice. In the UK and non-European Economic Area countries, this is authorized and regulated by the Financial Conduct Authority. In the European Economic Area, this is authorized and regulated by the Netherlands Authority for the Financial Markets. For full disclosures, visit blackrock.com/corporate/compliance/bid-disclosures.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Mamata's Bid to Game High Court Fails | BJP Displaying Weak Resolve in West Bengal | Voter Miffed

In Episode LXXXVI Mandi reviews Best Candy on the Block, Trick or Bid, and Cat Sudoku: Summer Festival. Suzanne revisits Tend and talks Adrift A Puzzletale and 3 Chapters. The Game Pie of the show is full of The Games We Binged Like Holiday Treats.  Thank you for listening! Please take a moment to rate us on your podcast listening platform. BGG Guild:  https://boardgamegeek.com/guild/4131 Bluesky:  https://bsky.app/profile/saltandsass.bsky.social YouTube:  https://www.youtube.com/c/SaltandSassGames  Twitch:  https://www.twitch.tv/saltandsassgames Email: SaltAndSassGames@gmail.com

Luke Hedrick, Dave Furfaro, and recurrent RFJC guest Robert Wharton are joined again today by Nicole Ng to discuss the FIBRONEER-IPF trial investigating Nerandomilast in patients with IPF. This trial was published in NEJM in 2025 and looked at Neradomilast vs placebo for treating patients with IPF, on or off background anti-fibrotic therapy. This agents is now FDA approved for pulmonary fibrosis, and understanding the trial results is essential for any pulmonary physician treating patients with IPF or progressive pulmonary fibrosis. Article and Reference Today’s episode discusses the FIBRONEER-IPF trial published in NEJM in 2025. Richeldi L, Azuma A, Cottin V, Kreuter M, Maher TM, Martinez FJ, Oldham JM, Valenzuela C, Clerisme-Beaty E, Gordat M, Wachtlin D, Liu Y, Schlecker C, Stowasser S, Zoz DF, Wijsenbeek MS; FIBRONEER-IPF Trial Investigators. Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis. N Engl J Med. 2025 Jun 12;392(22):2193-2202. doi: 10.1056/NEJMoa2414108. Epub 2025 May 18. PMID: 40387033. https://www.nejm.org/doi/abs/10.1056/NEJMoa2414108 Meet Our Guests Luke Hedrick is an Associate Editor at Pulm PEEPs and runs the Rapid Fire Journal Club Series. He is a senior PCCM fellow at Emory, and will be starting as a pulmonary attending at Duke University next year. Robert Wharton is a recurring guest on Pulm PEEPs as a part of our Rapid Fire Journal Club Series. He completed his internal medicine residency at Mt. Sinai in New York City, and is currently a pulmonary and critical care fellow at Johns Hopkins. Dr. Nicole Ng is an Assistant Profess of Medicine at Mount Sinai Hospital, and is the Associate Director of the Interstitial Lung Disease Program for the Mount Sinai National Jewish Health Respiratory Institute. Infographic Key Learning Points Why this trial mattered IPF therapies remain limited: nintedanib and pirfenidone slow (but do not stop) decline and often cause GI side effects. Nerandomilast is a newer agent (a preferential PDE4B inhibitor) with antifibrotic + immunomodulatory effects. Phase 2 data (NEJM 2022) looked very promising (suggesting near-“halt” of FVC decline), so this phase 3 trial was a big test of that signal. Trial design essentials Industry-sponsored, randomized, double-blind, placebo-controlled, large multinational study (332 sites, 36 countries). Population: IPF diagnosed via guideline-aligned criteria with central imaging review and multidisciplinary diagnostic confirmation. Intervention: nerandomilast 18 mg BID, 9 mg BID, or placebo; stratified by background antifibrotic use. Primary endpoint: change in FVC at 52 weeks, analyzed with a mixed model for repeated measures. Key secondary endpoint: time to first acute exacerbation, respiratory hospitalization, or death (composite). Who was enrolled Typical IPF trial demographics: ~80% male, mean age ~70, many former smokers. Many were already on background therapy (~45% nintedanib, ~30–33% pirfenidone). Notable exclusions included significant liver disease, advanced CKD, recent major cardiovascular events, and psychiatric risk (suicidality/severe depression), reflecting class concerns seen with other PDE4 inhibitors. Efficacy: what the primary endpoint showed Nerandomilast produced a statistically significant but modest reduction in annual FVC decline vs placebo (roughly 60–70 mL difference). Importantly, it did not halt FVC decline the way the phase 2 data suggested; patients still progressed. Important nuance: interaction with pirfenidone Patients on pirfenidone had ~50% lower nerandomilast trough levels. Clinically: 9 mg BID looked ineffective with pirfenidone, so 18 mg BID is needed if used together. In those not on background therapy or on nintedanib, 9 mg and 18 mg looked similar—suggesting the apparent “dose-response” might be partly driven by the pirfenidone drug interaction Secondary and patient-centered outcomes were neutral No demonstrated benefit in the composite outcome (exacerbation/resp hospitalization/death) or its components. Quality of life measures were neutral and declined in all groups, emphasizing that slowing FVC alone may not translate into felt improvement without a disease-reversing therapy. The discussants noted this may reflect limited power/duration for these outcomes and mentioned signals from other datasets/pooling that might suggest mortality benefit—but in this specific trial, the key secondary endpoint was not positive. Safety and tolerability Diarrhea was the main adverse event: Higher overall with the 18 mg dose, and highest when combined with nintedanib (up to ~62%). Mostly mild/manageable; discontinuation due to diarrhea was relatively uncommon (but higher in those on nintedanib). Reassuringly, there was no signal for increased depression/suicidality/vasculitis despite psychiatric exclusions and theoretical class risk. How to interpret “modest FVC benefit” clinically The group framed nerandomilast as another tool that adds incremental slowing of progression. They emphasized that comparing absolute FVC differences across trials (ASCEND/INPULSIS vs this trial) is tricky because populations and “natural history” in placebo arms have changed over time (earlier diagnosis, improved supportive care, etc.). They highlighted channeling bias: patients already on antifibrotics may be sicker (longer disease duration, lower PFTs, more oxygen), complicating subgroup comparisons. Practical takeaways for real-world use All three antifibrotics are “fair game”; choice should be shared decision-making based on goals, tolerability, dosing preferences, and logistics. Reasons they favored nerandomilast in practice: No routine lab monitoring (major convenience advantage vs traditional antifibrotics). Generally better GI tolerability than nintedanib. BID dosing (vs pirfenidone TID). Approach to combination therapy: They generally favor add-on rather than immediate combination to reduce confusion about side effects—while acknowledging it may slow reaching “maximal therapy.” Dosing guidance emphasized: Start 18 mg BID for IPF, especially if combined with pirfenidone (since dose reduction may make it ineffective). 9 mg BID may be considered if dose reduction is needed and the patient is not on pirfenidone (e.g., monotherapy or with nintedanib).

The Red Sox missed out on Alex Bregman and their offseason has entered disaster territory. -Huge Loss For Boston -Devers Trade In Hindsight -Bregman's Fit In Chicago -Where Will Bo Go? -Yankees / Bellinger -Kepler Suspended -Skubal Arbitration -1960 Cy Young Hindsight  Use promo code “Jared” to get up to $1000 in bonus credits AND a special pick on Underdog! PLAY HERE: https://play.underdogfantasy.com/pc-d2PyPbHAPu Get 20% off your DeleteMe plan when you go to join https://deleteme.com/BID and use promo code BID at checkout. 0:00 - Jake McCarthy 1:30 - NFL Playoffs 3:27 - Sox Lose Bregman 52:22- Cubs Sign Bregman 1:05:06 - Cody Bellinger 1:17:16 - Kepler Suspension 1:22:05 - Skubal Arbitration 1:41:35 - Cy Young Hindsight 1:55:12 - Jayhay Nuggs 1:58:00 - Final Thoughts Learn more about your ad choices. Visit megaphone.fm/adchoices

If you're looking for tips and ideas on how to leverage speaking opportunities, how to use speaking as your best for of visibility, or how to get booked to speak, you're in the right place. This is the best public speaking podcast for coaches, consultants, and service providers.Today's question comes from Brenda: She was asked to speak at a conference that is being held local to her. They are not paying their speakers and she's asking for advice on how to approach the situation because she is a paid speaker.***Listen to the Public Speaking Monetization podcast on Apple or SpotifyTo submit your question for a future Q&A episode go to: https://SpeakPipe.com/BID or DM me on LinkedIN or Instagram.~~~~~~~~~~~~~***Join IN Demand, the Membership at: https://SpeakAndStandOut.com/IND***Sign up for your own FREE Speaker Breakthrough Session at: https://SpeakAndStandOut.com/SBS *****Join the next Speaker Circle Community Call at https://SpeakAndStandOut.com/Speaker-Circle *****

In this first episode of the Heart of Rural America podcast for 2026, host Amanda Radke reconnects with her friend Calli Thorne, a ranch mom, entrepreneur, and fellow speaker. They discuss the challenges and rewards of operating a USDA federally-inspected beef plant named Yellowstone River Beef, their experiences in the cattle industry, and the importance of a positive mindset in overcoming business obstacles. Calli shares her strategies for balancing multiple responsibilities, including motherhood, business, and public speaking, by using a method of delegating or ditching tasks to focus on what truly matters. The episode delves into themes of entrepreneurship, leadership, and maintaining mental well-being while managing a busy, fulfilling life.00:00 Welcome to the Heart of Rural America00:34 Catching Up with Calli Thorne02:43 Challenges and Triumphs in the Beef Industry09:09 Balancing Business and Personal Life14:16 Mastering the Art of Saying No20:42 Empowering Women in Agriculture27:49 Final Thoughts and New Year MotivationShop Red Aspen: https://redaspenlove.com/pages/incentive?srsltid=AfmBOopNOkswz8PWWlG-dJfmkmIG30focRh90PpRD91xzZowMyvRnzNJ&pws=amandaradkePresented by Bid on Beef | CK6 Consulting | CK6 Source | Real Tuff Livestock Equipment | Redmond RealSalt | Dirt Road Radio | All American Angus Beef | Radke Land & CattleUse code RADKE for $10 off your next All American Angus Beef order at www.BidOnBeef.comSave on Redmond Real Salt with code RADKE at https://shop.redmondagriculture.com/Check out Amanda's agricultural children's books here: https://amandaradke.com/collections/amandas-booksLearn more about Bulletproofing Your Direct-To-Consumer Beef Enterprise: https://amandaradke.com/products/bulletproof-your-beef-business

Bid the holidays farewell with a Very Special One Shot featuring Tara's very first time in the GM chair and running a holiday themed one shot of her own design! And visit our Youtube page to enjoy the one shot with our beautiful faces!

HEADLINES:• Saudi Arabia Opens Stock Market to All Foreign Investors in Bid to Boost Capital Inflows• Dubai Basketball Takes Long-Term View in EuroLeague Debut, Rejects Big-Spending Model• Kayali Launches “Kayali Cares” With $250,000 Donation for Sudan Relief Newsletter: https://aug.us/4jqModrWhatsApp: https://aug.us/40FdYLUInstagram: https://aug.us/4ihltzQTiktok: https://aug.us/4lnV0D8Smashi Business Show (Mon-Friday): https://aug.us/3BTU2MY

In this episode of The Heart of Rural America podcast, host Amanda Radke welcomes her middle sister, Courtney Coughlin, a businesswoman, entrepreneur, and homeschooling mother of four. They discuss Courtney's various ventures, including her boutique CCXO and her cut flower business, Three Sisters Blooms. The sisters reflect on the importance of family, faith, and community, and share their predictions for business trends in 2026. They also offer practical advice for female entrepreneurs, emphasizing the value of authenticity, intentionality, and habit stacking. The episode concludes with a look ahead to 2026 and a special surprise for listeners.00:00 Introduction and Special Guest Announcement00:59 Wedding Preparations and Sisterly Competition01:50 Entrepreneurial Ventures and Family Business03:29 Flower Business and Community Engagement05:51 Beauty Products and Coaching Team07:41 Social Media Strategies and Predictions for 202611:38 In-Person Events and Shopping Trends16:07 Grandma Core and Embracing Slow Living18:18 Family Time and Work-Life Balance18:45 Scheduling Meaningful Moments19:19 Involving Kids in Work20:20 The Importance of Community and Family Farm21:07 Habit Stacking for a Better Life23:39 Admin Nights: Combining Work and Socializing26:26 Faith and Family Values28:39 Intentional Living in 202629:59 Final Thoughts and EncouragementShop Red Aspen: https://redaspenlove.com/pages/incentive?srsltid=AfmBOopNOkswz8PWWlG-dJfmkmIG30focRh90PpRD91xzZowMyvRnzNJ&pws=amandaradkePresented by Bid on Beef | CK6 Consulting | CK6 Source | Real Tuff Livestock Equipment | Redmond RealSalt | Dirt Road Radio | All American Angus Beef | Radke Land & CattleUse code RADKE for $10 off your next All American Angus Beef order at www.BidOnBeef.comSave on Redmond Real Salt with code RADKE at https://shop.redmondagriculture.com/Check out Amanda's agricultural children's books here: https://amandaradke.com/collections/amandas-booksLearn more about Bulletproofing Your Direct-To-Consumer Beef Enterprise: https://amandaradke.com/products/bulletproof-your-beef-business

We hope you got everything on your wishlist for the holidays, but we also know that plenty of people are packing up Amazon returns and exchanging presents. Those items can end up at Mac.Bid, and if you're lucky, someone's return could be your next cheap find. City Cast's Elizabeth Kauma and Megan Harris are talking about how these warehouses got here, what you need to know so you don't buy something broken, and whether it's even worth the risk to be placing bids. **This episode originally aired on March 18, 2024. Notes and references from today's show: 2022 Retail Returns Rate Remains Flat at $816 Billion [National Retail Federation] M@C Discount Business Profile [Better Business Bureau] Inside the booming business of reselling returned merchandise [Marketplace] This Is What Happens to All the Stuff You Don't Want [The Atlantic] Become a member of City Cast Pittsburgh at membership.citycast.fm. Want more Pittsburgh news?  Sign up for our daily morning Hey Pittsburgh newsletter. We're on Instagram @CityCastPgh. Text or leave us a voicemail at 412-212-8893. Interested in advertising with City Cast? Find more info here.

We look back at the biggest tech news of 2025, plus the U.S. halts new DJI drone imports, our ChatGPT “Wrapped” results, and our tech picks of the year!Ad-Free + Bonus EpisodesShow Notes via EmailWatch on YouTube!Join the CommunityEmail Us: podcast@primarytech.fm@stephenrobles on Threads@jasonaten on Threads------------------------------Sponsors:Copilot Money - Limited-time: Get 26% off your first year and a FREE month when you sign up at: try.copilot.money/primaryFramer - Start creating for free at framer.com/design, and use code PRIMARY for a free month of Framer Pro.------------------------------Links from the showJason on Movies on the Side PodcastNelko Bluetooth Thermal Shipping Label PrinterAnker Nano Charging Station, 7-in-1 USB-CThe Task Knife | Grovemade® Elgato Stream Deck +US bans new foreign drone models in a blow to Chinese giant DJI | CNN BusinessChatGPT launches a year-end review like Spotify Wrapped | TechCrunchApple warns employees not to leave the U.S. amid return delays - 9to5MacInstagram long-form videos and full control of your feed may happenApple Intelligence summaries might get warning labels. That's not enough. – Six ColorsTikTok gets reprieve with Trump order but with twist | Reuters How Apple Builds Iconic Stores: SVP Deirdre O'Brien Interview! - YouTubeDeepSeek privacy under investigation in US and Europe; App Store impactApple Invites - YouTubeAfter a bruising year, Sonos readies its next big thing: a streaming box | The VergeScarlett Johansson calls for anti deepfake laws after AI video goes viral | The VergeMy Teen Switched to iPhone 16e – Does He Regret It? - YouTubeIn an Email to Customers, Humane Just Delivered a Brutal Lesson in FailureWith Its AI-Powered Alexa+, Amazon Just Put Apple on NoticeOpenAI expands Deep Research to all paying ChatGPT usersHands on With the M4 MacBook Air: It's DelightfuliOS 19 Redesign Now Widely Rumored - MacRumorsApple adds new disclaimer on its website advertising delayed AI Siri features - 9to5MacDaring Fireball: Something Is Rotten in the State of CupertinoSonos has canceled its streaming video player | The VergeNintendo Switch 2 specs: 1080p 120Hz display, 4K dock, mouse mode, and more | The VergeAmazon Said to Make a Bid to Buy TikTok in the U.S. - The New York TimesLeaked iPhone 17 Pro Cases Show Huge Cutout for New Camera Bump - MacRumorsReport: iPadOS 19 to be 'more like macOS' in major overhaul - 9to5MacOpenAI is building a social network | The VergeiPhone 17 Air's Extreme Thinness Demoed in New Video - MacRumorsA judge just blew up Apple's control of the App Store | The VergeAirbnb Just Radically Changed Travel Again. Here's How.At I/O, Google Just Shipped Apple's AI PromisesA letter from Sam and Jony | OpenAI

In this episode of The Heart of Rural America podcast, Amanda Radke welcomes back Chris Earl of CK6 Consulting to discuss the current state of the American beef industry. They review the past year's sales and reflect on the significant improvements in beef pricing for producers. Chris shares his insights on the economic and political factors that are shaping the industry, the importance of resilience, and the fundamental role of faith in his personal and professional life. They also delve into their collaborative projects like Bid on Beef and the All American Angus Beef brand. Chris emphasizes the essential values of family, mentorship, and hard work, urging young cattle producers to leverage these favorable times for the industry. The episode concludes with a heartfelt reflection on the challenges and blessings of the cattle business, framed by their shared faith and commitment to service.00:00 Introduction and Guest Welcome00:44 Reflecting on a Successful Year02:49 Market Challenges and Opportunities07:12 Faith and Business Philosophy11:14 Family and Mentorship in Ranching15:35 Bid on Beef and Market Evolution25:02 Final Thoughts and Reflections

Two-thirds of Americans say government should ensure health care for all: poll | LiveNOW from FOX House GOP will not allow amendment vote to extend ObamaCare subsidies Republicans Clinch Democrats' Bid to Force Vote on ACA Subsidies - The New York Times Even MAGA Can't Stomach Trump's Vile Rob Reiner Post | HuffPost Latest News Epstein survivors and Senate Democrats ask for audit to determine if Epstein files have been "tampered with" - CBS News Fed Chair Warns Trump Admin May Be Seriously Exaggerating Jobs Numbers 'A Chilling Assertion': Trump Officials Falsely Claim Citizens Must Carry Immigration Docs to Prove Their Status | Common Dreams Noem Gets Most Awkward Fact-Check of Her Life on Deported Veterans | The New Republic FBI Leader Crumbles During Basic Questions About Threat of "Antifa" | The New Republic Accused gunman in Bondi Beach shooting charged with 15 counts of murder : NPR South Carolina measles outbreak 'accelerating,' driving hundreds into quarantine Trump unveils $12 billion aid package for farmers hit by trade war | Reuters

The Red Sox traded for Willson Contreras and we're breaking down the fit in Boston. -Willson Contreras To Red Sox -White Sox Sign Murakami -Padres Keep Michael King -Pirates Add Lowe -Jared Signs Dominican Stylist -Jayhay's Beard In The Red Zone -More Trades & Rumors! Use promo code “Jared” to get up to $1000 in bonus credits AND a special pick on Underdog! PLAY HERE: https://play.underdogfantasy.com/pc-d2PyPbHAPu For simple, online access to personalized and affordable care for Hair Loss, ED, Weight Loss, and more, visit https://Hims.com/BID Our listeners can get the Harry's Plus Trial Set for only $10 at https://Harrys.com/BID! Learn more about your ad choices. Visit megaphone.fm/adchoices

MRKT Matrix - Monday, December 22nd S&P 500 rises to start a holiday-shortened week, led by tech (CNBC) Bond Traders' Big Bet Targets US 10-Year Back to 4% Within Weeks (Bloomberg) Where Are Analysts Most Optimistic on Ratings for S&P 500 Companies Heading Into 2026? (FactSet) Bank of America's Moynihan Says AI's Economic Benefit Is ‘Kicking In More' (Bloomberg) Alphabet to Buy Data Center Partner Intersect for $4.75 Billion (Bloomberg) Larry Ellison Provides Personal Guarantee for Paramount's Bid for Warner (WSJ) Inside Tencent's deal to use Nvidia's best AI chips in Japan (FT) Exclusive: SoftBank races to fulfill $22.5 billion funding commitment to OpenAI by year-end, sources say (Reuters) Apollo cuts risk and stockpiles cash in preparation for market turmoil (FT) The Private-Credit Party Turns Ugly for Individual Investors ⁠(WSJ)⁠ --- Subscribe to our newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://riskreversalmedia.beehiiv.com/subscribe⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ MRKT Matrix by RiskReversal Media is a daily AI powered podcast bringing you the top stories moving financial markets Story curation by RiskReversal, scripts by Perplexity Pro, voice by ElevenLabs

This week, the focus is on diversification—and why it's getting harder to achieve. Portfolio Strategist Natalie Gill explains how the “diversification mirage,” a key theme in BII's 2026 outlook, is now showing up in real time. A small set of megaforces is increasingly dictating equity performance, meaning traditional attempts to diversify—whether toward equal-weighted indices or new regions—can amount to larger active positions than many investors realize.Natalie also breaks down how rising developed-market bond yields challenge the long-held assumption that long-term bonds reliably balance portfolios. Fiscal strains, shifting central bank stances, and policy divergence between the U.S. and other economies further complicate the diversification picture. As bond volatility rises and a small number of equity drivers dominate returns, investors may need to reconsider how and where true diversification can be found.The episode also highlights the growing disconnect between the Federal Reserve's policy posture and the more hawkish tone across Australia, Canada, and Japan—where fiscal dynamics and reopening risks are influencing long-term rates. These divergences, paired with delayed U.S. labor data and inflation considerations, shape the macro backdrop as markets enter the new year.Key Insights· Diversification is increasingly difficult as a handful of megaforces drive global equity performance.· Traditional diversifiers—such as long-term government bonds—provide less balance amid rising yields.· Policy divergence between the U.S. and other major central banks is creating new cross-market risks.· Fiscal concerns are influencing yield curves, particularly in Japan and the UK.· Portfolios may require more deliberate, active decisions and alternative sources of return to achieve true diversification. diversification, megaforces, capital markets, macro trends, bond yields, portfolio balance, market outlookThis content is for informational purposes only and is not an offer or a solicitation. Reliance upon information in this material is at the sole discretion of the listener. Reference to any company or investment strategy mentioned is for illustrative purposes only and not investment advice. In the UK and non-European Economic Area countries, this is authorized and regulated by the Financial Conduct Authority. In the European Economic Area, this is authorized and regulated by the Netherlands Authority for the Financial Markets. For full disclosures, visit blackrock.com/corporate/compliance/bid-disclosures.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Headlines: – Welcome To Mo News (02:00) – Republicans Clinch Democrats' Bid to Force Vote on Health Subsidies (05:15) – Trump Primetime Address: Previewing 2026 Agenda (09:30) – Bongino to Step Down From F.B.I. (14:00) – Rob Reiner's Son Nick Speaks in Court for First Time While Wearing Suicide Prevention Smock (16:15) – Rob and Michele Reiner's Children Jake and Romy Share Heartbreak: 'They Were Our Best Friends' (17:30) – Putin Calls Supporters Of Ukraine “Little Piglets” (20:15) – Warner Rejects Paramount's Hostile Bid, Saying Netflix Deal Still Superior (23:15) – Oscars Bolts from ABC to YouTube Starting in 2029 (27:00) – Laundry Lowdown: Debunking Myths About Cleaning Cashmere and Sweaters #ad (31:00) – Kansas School Dismisses Students Early for Winter Break After ‘Tremendous' Number of Illnesses Ravage Community (34:10) – On This Day In History (36:00) Thanks To Our Sponsors:  – LMNT⁠ - Free Sample Pack with any LMNT drink mix purchase –⁠ Industrious⁠ - Coworking office. 50% off day pass | Promo Code: MONEWS50 – Incogni - 60% off an annual plan| Promo Code: MONEWS – Aura Frames -  $35 off best-selling Carver Mat frames | Promo Code: MONEWS – Monarch - 50% off your first year | Promo Code: MONEWS

t's been said that the farm and ranch is the best place to raise children. As a mom of four kids, I feel so blessed to be able to teach kids about life, faith, family, community, and being true stewards of the land, livestock, and the people around them through the avenue of raising cattle.A calling from God led Tyler and I to become licensed foster parents in 2019, and since then, we've had a dozen kids come and go on the ranch. It's been a humbling experience and a shared family mission that has taught us plenty of lessons and has helped us grow in our faith, empathy, and commitment to serve others well.On this week's episode, I chat with fellow foster mom and Nebraska cattle rancher, Jessi Grote, to discuss her experiences as a foster mom and the new organization they have started to continue to serve families stepping into these hard spaces.Learn more about Foster The Love With Beef here: https://www.facebook.com/fosterlovewithbeefLearn more about foster care and adoption: https://americaskidsbelong.org/Presented by CK6 Consulting | CK6 Source | Real Tuff Livestock | Meats by Linz | Linz Heritage AngusPresented by Bid on Beef | CK6 Consulting | CK6 Source | Real Tuff Livestock Equipment | Redmond RealSalt | Dirt Road Radio | All American Angus Beef | Radke Land & CattleUse code RADKE for $10 off your next All American Angus Beef order at www.BidOnBeef.comSave on Redmond Real Salt with code RADKE at https://shop.redmondagriculture.com/Check out Amanda's agricultural children's books here: https://amandaradke.com/collections/amandas-booksLearn more about Bulletproofing Your Direct-To-Consumer Beef Enterprise: https://amandaradke.com/products/bulletproof-your-beef-business

Canadian journalist Nora Loreto reads the latest headlines for Tuesday, December 16, 2025.TRNN has partnered with Loreto to syndicate and share her daily news digest with our audience. Tune in every morning to the TRNN podcast feed to hear the latest important news stories from Canada and worldwide.Find more headlines from Nora at Sandy & Nora Talk Politics podcast feed.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-real-news-podcast--2952221/support.Help us continue producing radically independent news and in-depth analysis by following us and becoming a monthly sustainer.Follow us on:Bluesky: @therealnews.comFacebook: The Real News NetworkTwitter: @TheRealNewsYouTube: @therealnewsInstagram: @therealnewsnetworkBecome a member and join the Supporters Club for The Real News Podcast today!

¿Cuántos discursos grandilocuentes se han pronunciado a favor de la integración Latinoamericana? ¿Cuántos de estos apelan a la hermandad de los pueblos bolivarianos y a los lazos de sangre que unen a 'Nuestra América'? La historia regional está llena de intentos fracasados de integración que han producido una sopa de letras burocrática -CAN, CAF, OEA, Unasur, Mercosur, Celac, Prosur, AP, BID-, y un cementerio de organizaciones internacionales, muchas de las cuales ya terminaron en el basurero de la historia.Petro acaba de llamar a reunificar la Gran Colombia. ¿Qué fue la Gran Colombia, cómo fue su disolución y qué posibilidades tiene de revivir?¿Cómo es la historia de los intentos de integración regional, desde el Congreso ‘Anfictiónico' de Panamá que convocó Bolívar en 1826 hasta la fecha?Déjà vu es un pódcast de opinión de La Silla Podcast.La dirección es de Alejandro Lloreda y Luis Guillermo Vélez.La coordinación periodística y de podcast de La Silla Vacía es de Tatiana Duque.La producción es de Juana Rubio Tovar y Fernando CruzFoto: Archivo.Cada quince días un nuevo episodio.Más de La Silla Podcast:Ausencias es un podcast original de La Silla Vacía, realizado con el apoyo de la Fundación Ford. Disponible ya en  su plataforma de podcast favorita: ¿Quiere aprender de pódcast, hacer un pódcast como este o grabar sus contenidos sonoros?En La Silla Vacía le ayudamos y le damos las herramientas. Para mayor información y precios, consulte acáUn espacio de cuña en Huevos Revueltos o Déjà vu puede ser suyo, excepto para contenido político y electoral. Si tiene interés, escriba a podcast@lasillavacia.comMás de La Silla Vacía:En el Detectbot de La Silla Vacía puede chequear cadenas falsas. Escriba un chat a este link:‎Siga el canal de La Silla Vacía

Greg Amsinger joins BID to talk baseball cards, his passion for the game, his approach to working with former players, favorite moments on-air & more! Check out Greg's new show “Pack In Time” on @MLBNetwork December 14th @ 1:30pm ET. Use promo code “Jared” to get up to $1000 in bonus credits AND a special pick on Underdog! PLAY HERE: https://play.underdogfantasy.com/pc-d2PyPbHAPu Learn more about your ad choices. Visit megaphone.fm/adchoices

What happens when the richest people on Earth thirst for content? Sir Mike Schur and mere serf Joe Mande de-code Silicon Valley's playbook for Hollywood in the bidding war for Warner Bros. — and start an auction of their own.• Bid to win Joe Mande's custom hat for a good cause! Hosted on Acast. See acast.com/privacy for more information.

This episode is all about one of the smartest Amazon PPC bidding systems you'll ever come across. Priscilla, our guest, has spent years building her own custom bidding logic — not using software, but by creating a super detailed, data-heavy Excel system that she keeps improving over time. She breaks keywords into different behavior groups, figures out how many clicks each match type really needs to get a sale, checks organic rank, placements, inventory signals, and basically connects all those data points to decide exactly how every bid should move. What's cool is that she didn't learn this from any tool — she built it herself after studying a giant Excel file a VA once gave her. If you want to hear how someone can take PPC bidding way deeper than “raise bid, lower bid,” this episode is a super interesting look into how Priscilla thinks and why her approach works so well.We'll see you in The PPC Den!

As The Bid takes a short break for the holidays, we're introducing listeners to Market Take, the weekly macro podcast from the BlackRock Investment Institute. Market Take offers fast, digestible insights on what's moving markets - and this week, the focus is squarely on the labor market.Senior Economist Nicholas Fawcett breaks down why softer U.S. labor data is reinforcing expectations for another potential Federal Reserve rate cut. With hiring and labor supply both cooling, policymakers are watching these trends closely as they navigate the balance between inflation control and economic resilience. Nicholas also explores how delayed jobs data complicates the Fed's visibility into the economy, what markets are pricing in ahead of the December meeting, and how fiscal dynamics in the UK are shaping long-term bond views.Whether you're tracking monetary policy, macro signals, or broader capital markets trends, this short episode offers a concise view of the forces shaping the economic backdrop.Key Insights· The U.S. labor market is softening, raising the likelihood of another Fed rate cut.· Payrolls show a “no hiring, no firing” pattern as labor demand and supply slow.· Delayed jobs data may create noise, but markets still expect a quarter-point cut.· Fiscal tightening in the UK influences gilt valuations and long-term yield dynamics.· Labor market trends, inflation, and rates continue to guide broader market sentimentlabor market, inflation, interest rates, Federal Reserve, capital markets, macro trends, market commentary, economic outlookThis content is for informational purposes only and is not an offer or a solicitation. Reliance upon information in this material is at the sole discretion of the listener. Reference to any company or investment strategy mentioned is for illustrative purposes only and not investment advice. In the UK and non-European Economic Area countries, this is authorized and regulated by the Financial Conduct Authority. In the European Economic Area, this is authorized and regulated by the Netherlands Authority for the Financial Markets. For full disclosures, visit blackrock.com/corporate/compliance/bid-disclosures.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Today's Headlines: The Trump administration released its 33-page National Security Strategy — immediately praised by the Kremlin — outlining U.S. “dominance” in the Americas, embracing Middle East leaders “as they are,” warning Europe of “civilizational erasure,” and boosting far-right movements there. It also shifts U.S. policy in Africa toward extracting “latent economic potential,” and says avoiding conflict with China is suddenly a “priority.” At the Reagan Defense Forum, Pete Hegseth declared the end of America's “utopian idealism,” saying the military should ditch democracy-building and climate concerns for “practical interests.” Sure, Pete. Israel, Qatar, and the U.S. met to build relations after Israel's strike in Doha it was, of course, hosted by Steve Witkoff — who, along with Jared Kushner, also had a long call with Zelensky about territory and “security guarantees.” Meanwhile, the Supreme Court will hear Trump's effort to end birthright citizenship, despite the Constitution spelling it out pretty clearly and Trump threw a fit after pardoned Democrat Henry Cuellar didn't switch parties, accusing him of “disloyalty” and claiming “God was very happy” with his pardon. In other news, the Jan. 5 pipe-bomb suspect is cooperating with the FBI and says he planted them to support Trump, RFK Jr.'s HHS and anti-vax panel voted to end universal Hep B shots at birth, disregarding the risks to infants, and the Netflix–Warner Bros. merger is in trouble, with the Trump administration favoring a sale to Trump-ally-owned Paramount instead. Resources/Articles mentioned in this episode: The Guardian: Kremlin hails Trump's national security strategy as aligned with Russia's vision Whitehouse: National Security Strategy | The White House Politico:  Hegseth declares end of US 'utopian idealism' with new military strategy Axios: Scoop: Israel and Qatar hold secret meeting in New York to rebuild ties Axios: Zelensky, Trump advisers discuss Ukraine peace terms in 2-hour call Axios: Trump blasts pardoned Democrat as lacking "LOYALTY" NBC News: Pipe bomb suspect told FBI he believed 2020 election conspiracy theories PBS: Fact-checking the CDC panel's reasons for dropping universal newborn hepatitis B vaccine recommendation Fox Business: Trump administration reportedly skeptical about Netflix and Warner Bros.' $72B deal WSJ: Paramount Raises Concerns About Netflix's Bid for Warner Bros. Discovery Morning Announcements is produced by Sami Sage and edited by Grace Hernandez-Johnson Learn more about your ad choices. Visit megaphone.fm/adchoices

Jared Isaacman, the billionaire entrepreneur, philanthropist, and private astronaut, took on Capitol Hill this week in his second confirmation hearing as President Trump's pick for NASA's next leader. Here's what it could mean, plus: A Russian cosmonaut got kicked off a SpaceX flight for allegedly trying to steal spacecraft secrets, China's 1st reusable rocket Zhuque-3 reached orbit, but crashed and burned (and exploded) during landing, and Russia accidentally wrecked the only launch pad it has for astronauts with Thanksgiving's new ISS crew launch. Headlines: Russian Cosmonaut Pulled from SpaceX Crew 12 Mission over Alleged Incident at SpaceX HQ Russian Soyuz Launch Pad Damaged After Thanksgiving Crew Mission, Threatening Future Flights China's Land Space Rocket Nearly Sticks First Reusable Launch and Landing—Explodes on Return Scientists Find Time Passes Faster on Mars Than Earth, Thanks to Relativity Main Topic: Jared Isaacman's Bid to Become NASA Administrator Isaacman Returns for Second Senate Confirmation Hearing After Trump Re-Nominates Him Controversy Over SpaceX Ties, Conflict of Interest, and Elon Musk's Influence Bipartisan Support from Astronauts, Industry, and Lawmakers Highlights Isaacman's Appeal Project Athena Leaked: Isaacman's Vision for NASA and Debate on Earth Science Outsourcing Congressional Drama Over Artemis Funding, Gateway, and the US-China Race to the Moon Questions Around Space Shuttle Discovery's Possible Move to Houston Anticipation Builds for Senate Vote and NASA's Need for Stable Leadership Ahead of Artemis 2 Host: Tariq Malik Guest: Mike Wall Download or subscribe to This Week in Space at https://twit.tv/shows/this-week-in-space. Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free shows, a members-only Discord, and behind-the-scenes access. Join today: https://twit.tv/clubtwit

John talks about the many ways Trump is raking in big cash despite the Emoluments Clauses which are two provisions in the Constitution designed to prevent corruption by federal officials from foreign and domestic sources. Then, he welcomes back Rev. Barry Lynn to discuss the intersection of religion and current politics. And then, on the eve of Thanksgiving, John speaks with Jenique Jones who is WhyHunger's Executive Director. She makes sure its policies, culture and practices best fulfill WhyHunger's mission to end hunger and ensure everyone's basic human right to nutritious food. With a diverse background working in government and nonprofits, spanning the New York State Senate, the NYC Department of Education, and City Harvest, Jenique has been steadfast in her mission to improve the lives of marginalized and underserved populations and make a difference in the world.About WhyHunger's Hungerthon:2025 marks WhyHunger's 40th Hungerthon. Each year, we bring together thousands of supporters across the U.S. with listeners at SiriusXM and artists like Bruce Springsteen, Yoko Ono Lennon and SAINt JHN who believe in our shared vision of a hunger-free future!Hunger in America is surging. 47 million people – including 14 million children – don't get enough to eat. That's a staggering number in the world's wealthiest nation, and this crisis isn't slowing down.With devastating recent federal cuts threatening to strip food assistance from 22.3 million families, and 42 million SNAP recipients reeling from the Government shutdown, support for WhyHunger's Hungerthon has never been more critical.A Hungerthon donation has a powerful dual impact—delivering immediate nourishment to those in need and powering community solutions that work, long-term. A hunger-free tomorrow starts with all of us, today.Listeners can take action at siriusxm.com/hungerthon:Make a donation to help end hunger and its root causes. Bid on our exclusive celebrity auction items from SiriusXM like meeting Carrie Underwood, being a guest DJ, watching the Jets vs. Patriots from a VIP suite, winning Phish concert tickets, and more.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.